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 Life on Earth emerged in a hydrogen sulfide (H2S)-rich environment eons ago and with it protein 
persulfidation mediated by H2S evolved as a signaling mechanism. Protein persulfidation or S-
sulfhydration is a posttranslational modification of reactive cysteine residues, which modulate 
protein structure and/or function. Persulfides are difficult to label and study due to their reactivity 
and similarity with cysteine. Here, we report a facile strategy for chemoselective persulfide 
bioconjugation using dimedone-based probes, to achieve highly selective, rapid, and robust 
persulfide labeling in biological samples with broad utility. Using this method, we show that 
persulfidation is an evolutionarily conserved modification and that waves of persulfidation are 
employed by cells to resolve sulfenylation and prevent irreversible cysteine overoxidation to 
preserve protein function. We report an age-associated decline in persulfidation which is conserved 
across evolutionary boundaries. Accordingly, dietary or pharmacological interventions to increase 
persulfidation associate with increased longevity and improved capacity to cope with stress 
stimuli. 
 
One Sentence Summary: A new method for chemoselective persulfide labeling reveals the role 














Although considered a toxic gas for more than a century, hydrogen sulfide (H2S) was one 
of the essential ingredients required for life to emerge on Earth (Patel et al., 2015). Early anaerobic 
bacteria flourished in H2S-rich environments and even used H2S instead of water for the first 
photosynthetic process (Filipovic et al., 2018a; Wang, 2012). Two decades ago H2S reemerged as 
an important signaling molecule produced by cells (Filipovic et al., 2018a; Paul and Snyder, 2012; 
Szabó, 2007; Wang, 2012). Genetic deletion of the H2S producing enzyme cystathionine γ-lyase 
(CSE) can lead to hypertension (Yang et al., 2008). Animals exposed to H2S enter a suspended 
animation-like state (Blackstone, 2005), while dietary restriction-induced stress resistance and 
lifespan extension depends on intracellular H2S production (Hine et al., 2015). Despite beneficial 
effects of H2S, observed in a plethora of pathological states (Filipovic et al., 2018a; Paul and 
Snyder, 2012; Szabó, 2007; Wallace and Wang, 2015), the mechanism or mechanisms underlying 
these effects remain poorly characterized. However, its role in the oxidative posttranslational 
modification (oxPTM) of cysteine residues, known either as protein S-sulfhydration or 
persulfidation, is thought to be one of its main beneficial mechanisms of action (Filipovic et al., 
2018b; Paul and Snyder, 2015).  
Cysteine is a rare amino acid residue that often occurs in functional sites of proteins and 
represents a site for redox control of protein function (Marino and Gladyshev, 2010; Paulsen and 
Carroll, 2013). For example, hydrogen peroxide (H2O2) signals via the oxidation of cysteine 
residues to sulfenic acids (P-SOH), while part of nitric oxide signaling could be explained by 
cysteine S-nitrosation (Foster et al., 2009; Paulsen and Carroll, 2013). A variety of chemical 
approaches have been used to label and study cysteine modifications, leading to a broad range of 
fundamental and applied advances (Furdui and Poole, 2014; Paulsen and Carroll, 2013). However, 
protein persulfides (P-SSH) and their role in cell signaling managed to remain understudied, due 
to the fact that P-SSH are very reactive and their reactivity is similar to that of cysteine residues 
(Cuevasanta et al., 2015; Filipovic et al., 2018a; Pan and Carroll, 2013), has made it difficult to 
design tools for selective labeling, hampering a better understanding of the function of this specific 
oxPTM. Current methods rely on blocking both thiols and persulfides with electrophiles and then 
releasing the latter with a reducing agent, but this approach is linked to many caveats (Dóka et al., 
2016; Filipovic et al., 2018a; Reisz et al., 2013). 
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On the other hand, due to their enhanced nucleophilicity persulfides react readily with  
reactive oxygen species (ROS), while H2S itself is a poor ROS scavenger (Cuevasanta et al., 2015; 
Filipovic et al., 2018a; Ono et al., 2014). Given the fact that ROS play an important role in 
signaling (D’Autréaux and Toledano, 2007; Finkel, 2011) and aging (Finkel and Holbrook, 2000) 
it is tempting to speculate that the general beneficial effects of H2S are evolutionary conserved and 
conveyed through protein persulfidation.  
To better understand persulfidation in vivo, we explored the phenomenon that, if first 
transformed to mixed aromatic disulfides, protein persulfides could be selectively labeled by 
certain nucleophiles. Here we report the development of a new, dimedone-based method that 
enables chemoselective persulfide bioconjugation of proteins from a wide range of source 
materials in vitro and in vivo. Using this new method, we report that persulfidation plays an 
integral role in hydrogen peroxide-based signal transduction. We also found that protein 
persulfidation decreases with age and is maintained by interventions that increase lifespan across 
evolutionary boundaries, and may thus play a previously unrecognized protective role against 
aging. 
RESULTS  
Development of dimedone switch method  
To be able to use nucleophilic substitution to tag persulfides, P-SSH need to be transformed into 
a mixed disulfide (Wedmann et al., 2016; Zhang et al., 2014) in such way that one of the sulfurs 
in the S-S bond possesses much more enhanced electrophilicity (Figure S1A). Despite their 
selectivity in sulfenic acid labeling (Klomsiri et al., 2010; Paulsen and Carroll, 2013; Yang et al., 
2014), dimedone-based probes (Figure 1A) could be an excellent candidate for the nucleophile. 
They are additionally attractive candidates since a plethora of those probes with different reporting 
moieties are already available and thoroughly tested (Furdui and Poole, 2014; Paulsen and Carroll, 
2013). However, for dimedone-based probes to be used in P-SSH labeling, the initial thiol blocking 
reagent must block sulfenic acids as well. 4-chloro-7-nitrobenzofurazan (NBF-Cl) fulfills this 
criterion, since it is used as a tool for detection of thiols, amines and sulfenic acids (Bernal-Perez 
et al., 2012; Ellis and Poole, 1997) (Figure 1B). We initiated our study by monitoring the labeling 
of the low molecular weight persulfide, N-methoxycarbonyl penicillamine persulfide  (nmc-PSSH, 
(Artaud and Galardon, 2014)) (Figure 1C). Nmc-PSSH reacted readily with NBF-Cl resulting in 
a characteristic absorbance maximum at 412 nm (Figure 1D). The addition of an equimolar 
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amount of dimedone led to a fast disappearance of the 412 nm peak, suggesting that switching did 
occur (Figure 1E). ESI-TOF MS/MS analysis of the reaction mixture confirmed that the two main 
products are the NBF-SH and dimedone labeled nmc-PSSH (Figure 1C, Figure S1B-F).  
We then evaluated the selectivity of the dimedone switch method by using human serum 
albumin (HSA) as a model (Cuevasanta et al., 2015). HSA has 17 disulfides and 1 free thiolate 
and is therefore both a good control and an example of a protein with an oxPTM of cysteine. 
Human serum albumin (HSA-SH), its sulfenylated (HSA-SOH) and persulfidated (HSA-SSH) 
forms reacted with NBF-Cl to generate products with distinct absorbance maxima that fit well to 
those reported in the literature (Ellis and Poole, 1997) (Figure S1G, I, K). The addition of dimedone 
caused tag-switching only in the HSA-SSH sample (Figure 1F, G, Figure S1H, J) resulting in the 
loss of HSA-SS-NBF absorbance and formation of the HSA-S-dimedone and NBF-SH products. 
Separation of treated samples by electrophoresis and subsequent immunoblotting with anti-
dimedone antibody (Seo and Carroll, 2009) gave a positive signal for HSA-SSH only (Figure 2A). 
To confirm the labeling of naturally occurring persulfides, we used thiosulfate sulfur transferase 
(TST, also known as rhodanese), an enzyme that forms a persulfide during its catalytic cycle, as a 
model (Filipovic et al., 2018b). Both immunoblotting with anti-dimedone antibody (Figure 2B) 
and ESI-TOF-MS (Figure 2C) revealed TST labeled with dimedone. 
Dimedone switch method for MS analysis 
With these data in hand, we envisioned that the dimedone switch method could enable the 
installation of various payloads onto a protein of interest that would allow specific 
identification/visualization. We first used DCP-Bio1, a biotinylated form of dimedone (Figure 
1A). Persulfides of HSA and GAPDH showed positive staining (Figure S2A, B), as detected by 
Cy5-streptavidin. Separation of samples by streptavidin magnetic beads and subsequent in-gel 
detection of green fluorescence originating from amino groups labeled with NBF-Cl (Figure 1B), 
showed the selective labeling of P-SSH but not other oxPTM (Figure S2A, B).  
Next, we tested if the method can be used for proteomic analysis. TST persulfide was tag-
switched with DCP-Bio1 and subjected to either trypsin or chymotrypsin digestion. Combined 
they covered 95% of the structure (Figure S2C, Supporting Data S1, S2) and only C248, present 
as a persulfide in the active site of the enzyme, was found to be labeled (Figure S2C). Other 
cysteine residues and several lysine residues were labeled with NBF alone (Supporting Data S1, 
S2), according to the reaction scheme in Figure 1B.  
 6 
 
Fig. 1. Probing dimedone switch strategy for persulfide labeling.  
(A) (Upper) Labeling of sulfenic acids with dimedone. (Lower) Structures of dimedone-based probes.  
(B) Proposed dimedone switch strategy for persulfide labeling. In the first step proteins react with 4-chloro-7-
nitrobenzofurazan (NBF-Cl) to label persulfides, thiols, sulfenic acids, and amino groups. Reaction with amino groups 
gives characteristic green fluorescence. In the second step, NBF tag is switched by a dimedone-based probe, 
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(C) Model switch reaction with 100 µM N-methoxycarbonyl penicillamine persulfide (nmc-PSSH), 100 µM NBF-Cl 
and 500 µM dimedone. MS analysis reveals formation of 4-thio-7-nitrobenzofurazan (535 nm) and dimedone labeled 
nmc-penicillamine, which under MS/MS conditions decomposes along the blue or red dash line. Numbers given in 
the brackets represent calculated m/z for the observed ions.  
(D) Time-resolved spectra for the reaction of 100 M nmc-PSSH with 100 M NBF-Cl (pH 7.4, 23 C). Arrows 
indicated disappearance of NBF-Cl and appearance of nmc-PSS-NBF adduct at 412 nm. 
(E) Time-resolved spectral changes upon addition of 200 M dimedone to a reaction mixture shown in (D) (pH 7.4, 
23 C). Inset: Kinetics of decay of 412 nm absorbance maximum after addition of dimedone. 
(F-G) 23 µM HSA-SH was left to react with 100 µM NBF-Cl over 30 min in phosphate buffer (50 mM, pH 7.4) with 
1% SDS, at 37 °C and then 200 µM dimedone was added. UV-Vis spectral changes (F) and kinetic traces (G) show 
the decay of the 422 nm absorbance and the appearance of a 535 nm peak.  
 
Furthermore, we used DCP-Bio1 labeling to identify the endogenously persulfidated proteins in 
human erythrocytes (Figure 2D, Table S1). Out of 56 identified proteins more than half were 
previously reported to contain reactive cysteine residues. These proteins were either found to be 
prone to cysteine oxidation in red blood cells (RBC) depleted of haemoglobin (Delobel et al., 
2016) or treated with diamide (Zaccarin et al., 2014), in RBC from peroxiredoxin II deficient mice 
(Yang et al., 2012) or are found to be directly persulfidated (Valentine et al., 1987). More 
importantly, both enzymes involved in H2S production in erythrocytes were also found to be 
persulfidated: 3-mercaptopyruvate sulfur transferase (MPST) and methanethiol oxidase. The 
former is known to form a persulfide during the catalytic cycle (Yadav et al., 2013) while the latter 
produces both H2O2 and H2S (Pol et al., 2018), facilitating the oxidation of a cysteine residue to a 
sulfenic acid first and then to form a persulfide. In addition, peroxiredoxins, known to form 
sulfenic acid during the catalytic cycle (Wood et al., 2003), were found to be persulfidated as well. 
It is also worth noting that all identified peptides, even those not falling within selection criteria 
(at least 2 reliable peptides and -10logP>50) originated from cysteine containing proteins, 
indicative of the very high selectivity of this approach. 
In-gel detection of intracellular protein persulfidation 
We next tested the possibility of detecting P-SSH directly in gel, by installing a Cy5-fluorescence 
moiety through Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC, click chemistry). In 
addition to labeling cysteines, NBF-Cl also reacts with amino groups giving a characteristic 
fluorescence with ex at 488 nm (Bernal-Perez et al., 2012). Low NBF-Cl/protein ratio showed 
that NBF-persulfide adduct contributed to the overall green fluorescence detected in the gel, 
resulting in the loss of green fluorescence upon switching (Figure S2D). Commercially available 
TST (already partially present as a persulfide) was incubated with either thiosulfate or 
dithiothreitol (DTT) to form a fully persulfidated or fully reduced form, respectively. 20 μM 
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enzyme was mixed with 50 μM NBF-Cl and the persulfide was visualized using Daz-2/Cy5 
CuAAC. While both untreated and thiosulfate treated showed Cy5 signal, the green fluorescence 
signal was significantly reduced in the fully persulfidated enzyme, despite the same load. On the 
other hand, the green fluorescence signal was much stronger in the fully reduced enzyme, 
suggesting that at low NBF-Cl/protein ratio, switching caused by the dimedone-based probe could 
affect the intensity of green fluorescence (Figure 2SD), so we opted for using at least 10-fold 
excess of NBF-Cl (Figure S2E). This use of NBF-Cl in excess additionally offered the opportunity 
to use the green fluorescence as a measure of the total protein load and to therefore quantify the 
persulfidation levels by measuring the Cy5/488 fluorescence signal ratio. Different components of 
click chemistry did not show any interference with the labeling in the presence of NBF-Cl (Figure 
S2F). Together these data presage the utility of the dimedone switch approach in biological 
environments. 
Cell lysis with NBF-Cl, switching with DAz-2 (that bears a biorthogonal azide group) and 
then the subsequent coupling to Cy5-alkyne via a CuAAC reaction resulted in the labeling and in-
gel detection of a red fluorescence signal only when all three reagents were used (Figure 2E). We 
found that lysis with 5 mM NBF-Cl is already sufficient to give maximal persulfide signal (Figure 
S2G). Treatment of cell lysates with TCEP to reduce the disulfide bond formed in the reaction of 
NBF-Cl and protein persulfidation, diminished the detected Cy5 fluorescence (Figure 2F), 
confirming the chemical basis for the dimedone switch approach proposed in Figure 1B. 
Additionally, treatment of HeLa cells with different sources of H2S increased the intracellular 
persulfidation levels several-fold (Figure 2G, H). 200 nM mitochondria-targeted H2S donor, 
AP39, induced comparable increase as 200 M Na2S, confirming the strong pharmacological 
potential of this compound (Figure 2G, H). 
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Figure 2. Protein persulfide labeling and identification. 
(A-B) Selectivity of dimedone-switch method for protein persulfides. Human serum albumin (A) and TST (B) were 
used as a model. Dimedone labeling was visualized by rabbit polyclonal anti-dimedone antibody. Ponceau S staining 
was used for the protein load.  
(C) Deconvoluted mass spectra 20 μM rhodanese (black), rhodanese treated with 100 μM NBF-Cl (blue) and 
rhodanese treated first with 100 μM NBF-Cl then with 500 μM dimedone (red). 
(D) Schematic depiction of the protocol used for the proteomic analysis of endogenous persulfidation in RBC. 
(E) In-gel detection of P-SSH levels in cells using CuAAC. HeLa cells were lysed either with or without 5 mM NBF-
Cl and probed for persulfide labeling with DAz-2 and Cy5-alkyne by CuAAC. Gels were also stained with Coomassie 
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Brilliant Blue. Fire pseudo-colouring was used to visually enhance the signal. Green fluorescence corresponds to the 
total protein load (NBF-protein adducts).  
(F) After lysis with 5 mM NBF-Cl samples were treated with or without 5 mM TCEP and labeled with Daz-2/Cy5-
alkyne CuAAC.  
(G-H) Protein persulfidation levels in HeLa cells treated with different H2S donors: 200 μM Na2S (H2S) for 45 min, 
200 μM GYY4137 for 2 h, 200 nM AP39 for 2 hr and 2 mM D-cysteine for 1 hr. Ratio of Cy5/488 signals is used for 
the quantification (G). Data shown as mean ± SD of 3 individual experiments.  
 
Persulfidation is evolutionarily conserved and controlled by H2S generation from cysteine 
metabolism 
Although initial studies suggested that the main source of intracellular persulfides is H2S, produced 
predominantly by CSE (Figure 3A) (Filipovic et al., 2018b; Mustafa et al., 2009; Paul and Snyder, 
2012), recent findings questioned this by claiming that persulfides are synthesized during protein 
translation and are not related to the reverse transsulfuration pathway or cysteine catabolism 
(Figure 3A) (Akaike et al., 2017). Persulfidation levels were significantly reduced in mouse 
embryonic fibroblasts (MEFs) originating from CSE-/- animals (Figure 3B). Interestingly, repeated 
cell splitting of the same cell line leads to less pronounced differences in these levels due to 
compensatory overexpression of cystathionine-β-synthase (CBS, Figure S3A, B). CSE is 
profoundly diminished in Huntington’s Disease (HD), a neurodegenerative disease triggered by 
the expansion of  polyglutamine repeats in the huntingtin protein (Paul et al., 2014). In striatal cell-
line models of HD (STHdhQ7/Q7 and STHdhQ111/Q111) harboring 7 and 111 polyglutamine repeats, 
we now show that the lack of CSE results in the barely detectable P-SSH levels in the 
STHdhQ111/Q111 cells  (Figure 3C). CSE is known to be the predominant source of H2S in this cell 
type (Paul et al., 2014; Sbodio et al., 2016). Furthermore, inhibition of cystine transporter, system 
xc
¯ with erastin also resulted in the loss of protein persulfidation (Figure 3D). Additionally, 
pharmacologically induced overexpression of CSE by Golgi stressor, monensin (Sbodio et al., 
2018), on the other hand, resulted in an increase of intracellular persulfidation (Figure 3E).  
We expanded the screening to different phyla and regna, and in all of them endogenous 
persulfidation was found to be controlled by H2S produced via the transsulfuration pathway or 
cysteine catabolism (Figure 3A). We used an E. coli strain that is transformed with the phsABC 
operon (pSB74 plasmid) encoding for thiosulfate reductase, causing increased H2S production. 
Treatment of these bacteria with thiosulfate resulted in a two-fold increase of bacterial protein 
persulfidation when compared to control (Figure 3F). On the other hand, cth-1 and mpst-3 mutants 
of C. elegans (lacking CSE and MPST, respectively, Figure 3G) also showed lower P-SSH levels. 
Drosophila melanogaster flies overexpressing CSE (Snijder et al., 2015) showed increased P-SSH 
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levels (Figure 3H) while kidneys from CSE-/- mice showed reduced persulfidation levels (Figure 
3I). Finally, endogenous persulfidation could be observed in human RBC, in both membrane and 
cytoplasm, confirming the proteomic data (Figure 3J, Table 1). 
The dimedone switch method was also successfully applied for the visualization of 
intracellular persulfides by confocal microscopy (Figure 3K, Figure S3C). MEFs lacking CSE 
showed barely any detectable intracellular levels of P-SSH, while both H2S and D-cysteine 
treatments increased those levels several-fold. Independent of CSE, both sources of H2S increased 
the P-SSH levels highlighting the essential role of H2S in protein persulfide formation (Figure 3K, 
Figure S3C). Furthermore, wide-field fluorescence deconvolution microscopy provided the first 
high-resolution images of intracellular persulfidation (Figure S3D-F). The P-SSH signal is 
dispersed throughout the cell, with some of it being detected even in the nucleus. The P-SSH signal 
in D-cysteine treated cells seems to be predominantly localized in mitochondria, in accordance 
with the fact that D-cysteine is a substrate for cysteine catabolism path via MPST (Shibuya et al., 
2013) (Figure S3F).  
Broad applicability of dimedone switch method: antibody microarray  
To further showcase the applicability of the dimedone switch method, we used an antibody 
microarray-like approach, where antibodies for specific proteins were immobilized on an NHS-
activated surface (Figure 3L). As the samples carry both green and red fluorescence, reflecting 
the total load and P-SSH levels respectively, proteins of interest could be analyzed by this approach 
and their P-SSH levels assessed. We selected antibodies against a series of proteins (Figure 3L) 
for which persulfidation has been shown, or which form persulfides in their catalytic cycles. In 
general, the lack of CSE reduced P-SSH levels of target proteins while D-cysteine treatment 
increased it, albeit with different efficiencies. The selectivity of the method is once more 
demonstrated, as enzymes reported to form persulfides at their active sites during the H2S 
oxidation, sulfide:quinone oxidoreductase (SQOR) and TST, showed high endogenous P-SSH 
levels with minimal changes upon further D-cysteine treatment. However, a significant decrease 
of steady-state persulfide levels of those enzymes was observed in cells lacking CSE. Aside from 
the proteins whose persulfidation has already been demonstrated (GAPDH, HSP70, Keap 1, ß-
actin, Parkin) (Mustafa et al., 2009; Vandiver et al., 2013; Yang et al., 2013; Zhang et al., 2014), 
this approach led to the observation that manganese superoxide dismutase (MnSOD) could be 
persulfidated as well (Figure 3L). Unlike prokaryotes, most eukaryotic MnSOD have at least one 
cysteine residue (Figure 3M, Figure S3G) and exhibit strong product inhibition by H2O2 (Hearn 
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et al., 2001). Our experiments with human recombinant MnSOD showed that a 15 min exposure 
to a 3-fold excess of H2O2, inhibited MnSOD activity (0.15 ± 0.06 x 10
3 U/mg vs. 2.91 ± 0.07 x 
103 U/mg in the control) while the co-treatment with 5-fold excess of H2S rescued the enzymatic 
activity (1.92 ± 0.07 x 103 U/mg) (Figure 3N). MS/MS analysis of human recombinant MnSOD 
treated with H2O2 and H2S and labeled by the dimedone switch method (using DCP-Bio1) 
confirmed that C193 was indeed persulfidated (Figure S3H, I, Data S3, S4). Other studies have 
pointed out that the same cysteine residue is redox sensitive (Matsuda et al., 1990). Furthermore, 
persulfidated MnSOD was more resilient to tyrosine nitration by peroxynitrite (yield of nitration 
per subunit 3±2%) when compared to the control (15±4%/subunit), suggesting that persulfidation 
of MnSOD might serve as a protective mechanism against detrimental enzyme nitration found in 
many disease states (Szabó et al., 2007). 
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Figure 3. Intracellular persulfidation is evolutionarily conserved and controlled by H2S 
producing enzymes. 
(A) Intracellular H2S production is catalyzed by cystathionine gamma lyase (CSE) and cystathionine beta synthase 
(CBS), via the reverse transsulfuration pathway, and by 3-mercaptopyruvate sulfur transferase (MPST) in cysteine 
catabolism pathway. Hcy: homocysteine; Cys: cysteine; 3MP: 3-mercaptopyruvate; CAT: cysteine aminotransferase; 
DAT: D-amino acid aminotransferase.  
(B) P-SSH levels in MEFs from wild type and CSE-/- mice. Inset: Western blot analysis of CSE levels. n = 3. 
(C) P-SSH levels in STHdhQ7/Q7 and STHdhQ111/Q111 cells. Inset: Western blot analysis of CSE levels. n = 3. 
(D) The effect of 1 and 10 M Erastin on P-SSH levels in WT MEF cells. n = 3. 
(E) P-SSH levels in WT MEF cells for control, C, and treated with 1 M Monensin, Mone. Inset: Western blot analysis 
of CSE levels. n = 3. 
(F) P-SSH levels in E. coli without or with phsABC operon (pSB74 plasmid) that encodes thiosulfate reductase and 
results in H2S production. TS- thiosulfate. n = 3. 
(G) P-SSH levels in wild type (N2), cth-1 (CSE) and mpst-1 (MST) Caenorhabditis elegans mutants. ~ 4000 worms 
per sample. n = 3. 
(H) P-SSH levels in wild type (y1w118) Drosophila melanogaster and flies with different levels of CSE overexpression. 
3-4 flies per samples. n = 3. 
(I) P-SSH levels in kidney extracts form wild type (C57BL/6J) and CSE-/-
 
mice. n = 5 animals. 
(J) Protein persulfidation in RBC membrane and cytosol from a healthy human donor.  
(K) Confocal microscopy images of intracellular protein persulfide levels of WT and CSE-/- MEFs treated or not with 
200 μM Na2S or 2 mM D-cysteine for 1 hr. Cy5 signal corresponds to protein persulfides, 488 nm signal corresponds 
to NBF-adduct with amino groups of proteins. Nuclei are stained with DAPI. Scale bar 20 μm. 
(L) Antibody microarray-like approach to study persulfidation status of specific proteins. Schematic depiction of the 
method (lower part) and the actual readout (upper part) for the ten listed proteins. Cell lysates from WT, CSE-/-
 
and 
WT MEFs treated with D-cysteine (2 mM, 1 hr) were compared. Results are presented as mean ± SD from 3 
independent experiments.  
(M) Ribbon structure of two subunits from human MnSOD (PDB: 1pl4), highlighting the cysteine residues and 
manganese containing active site. 
(N) SOD activity of 13 μM MnSOD, MnSOD pretreated with 3-fold excess of H2O2 (15 min, 37 °C) and MnSOD 
pretreated with both 3-fold excess of H2O2 and 5-fold excess of H2S. SOD activity was measured using cytochrome c 
as a reporting molecule and xanthine/xanthine oxidase system as a source of superoxide. Results are presented as 




Persulfidation is intrinsically linked to H2O2  
For H2S to be able to modify cysteine residues, an oxidant is required - a role that could be played 
by H2O2. Protein sulfenylation, as a consequence of H2O2 production, represents an important 
signaling event (Paulsen and Carroll, 2013; Poole et al., 2004). However, P-SOH formation should 
be controlled in order to prevent overoxidation of cysteine residues to sulfinic (P-SO2H) and 
sulfonic acids (P-SO3H) that results in a loss of protein function (Figure 4A). Previous studies 
showed that protein P-SOH react two orders of magnitude faster with H2S, than with glutathione 
(Cuevasanta et al., 2015) and our proteomic analysis of persulfidated proteins in RBC showed a 
significant overlap with proteins known to be sulfenylated (Table S1). We hypothesized that the 
reaction of H2S with P-SOH could represent an integral part of H2O2-induced redox signaling and 
the main way for resolving P-SOH back to thiols. To test this, we first exposed CSE+/+ and CSE-/- 
MEFs to H2O2. While 100 M H2O2 induced no detectable increase in P-SOH levels in CSE
+/+ 
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cells, a massive increase in sulfenylation was detected in CSE-/- that decreased as exposure time 
increased (Figure 4B). 500 M H2O2 was required to cause the same magnitude of P-SOH 
formation in CSE+/+ cells (Figure 4B). This effect that could be completely abolished by pre-
incubating the cells with 100 M H2S donor GYY4137 (Figure S4A). Conversely, the P-SSH 
levels in CSE+/+ cells increased time-dependently when treated with 100 and 500 M H2O2
 but 
remained very low in CSE-/- cells (Figure 4C). Recent development of selective probes for sulfinic 
acids (P-SO2H) (Akter et al., 2018) allowed us to test how sulfinylation changes in cells lacking 
endogenous H2S. A strong overall increase of sulfinylation was observed in CSE
-/- cells treated 
with 100 M H2O2 for 15 min, but this P-SO2H dropped back to normal after 30 min suggesting 
that those cysteines either became hyperoxidized or reduced back by sulfiredoxin (Akter et al., 
2018) (Figure 4D). 500 M H2O2
 caused increase of sulfinylation only on a selected group of 
proteins in CSE+/+ cells. 
To address how endogenous H2S controls H2O2-induced cysteine oxidation on a molecular 
level we opted for monitoring the cysteine oxidation status in a redox sensitive protein, DJ-1. C106 
is known to undergo oxidation to a sulfinic (Akter et al., 2018) and even sulfonic acid (Fernandez-
Caggiano et al., 2016), while our proteomic analysis indentified DJ-1 as a target for persulfidation 
as well (Suppoting Table S1). CSE+/+ and CSE-/- cells were treated with 100 M H2O2
 for 15 and 
30 min, labeled for P-SOH (using DCP-Bio1), P-SSH (using DCP-Bio1 as a switching reagent) 
and P-SO2H (using BioDiaAlk) and immunoprecipitated. In parallel, using an antibody selective 
for C106 sulfonic acid we assessed the DJ-1-SO3H levels in those samples (Figure 4E, Figure 
S4B). H2O2 treatment of CSE
+/+ cells resulted in increased persulfidation of DJ-1 (in 15 and 30 
min) and increased sulfonylation after 30 min. However, in CSE-/- cells a further decrease of DJ1-
SSH levels was observed in cells treated with H2O2 but a pronounced increase of DJ1-SOH, DJ1-
SO2H and DJ1-SO3H levels. Furthermore, the basal levels of these modifications were much 
higher in untreated CSE-/- cells when compared to CSE+/+ (Figure 4E, Figure S4B). Taken together 
these data confirmed that persulfidation, controlled by endogenous H2S production, is an integral 
part of H2O2-induced redox changes in proteins. 
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Figure 4. Endogenous H2S controls cysteine oxidation caused by H2O2. 
(A) The proposed mechanism for the redox switching between H2O2-induced thiol oxidation and persulfidation. 
(B) Protein sulfenylation in CSE+/+
 
and CSE-/- MEF cells treated with 100 or 500 μM H2O2 for 15 or 30 min. Blots 
were visualized with streptavidin-488 on a Typhoon FLA 9500. GAPDH was used as a loading control. Representative 
blots of n=4. 
(C) Protein persulfidation in CSE+/+. Fire pseudo-colouring was used to visually enhance the PSSH signal. Green 
fluorescence corresponds to the total protein load (NBF-protein adducts). Ratio of Cy5/488 signals is used for the 
quantification. n = 3. 
(D) Protein sulfinylation in CSE+/+ and CSE-/- MEF cells treated with 100 or 500 μM H2O2 for 15 or 30 min. Blots 
were visualized with streptavidin-Cy3. GAPDH was used as a loading control. Representative blots of n = 5. 
(E) Persulfidation, sulfenylation, sulfinylation and sulfonylation of DJ-1. CSE+/+ and CSE-/- MEF cells were treated 
with 100 μM H2O2 for 15 or 30 min, labelled for P-SSH, P-SOH and P-SO2H using biotnylated reagents, 
immunoprecipitated with anti DJ-1 antibody immobilized to agarose beads and bloted with anti-biotin antibody. For 
sulfonylated DJ-1, antibody selective for C106 sulfonic acid of DJ-1 was used. n = 4. 
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P-SSH waves follow P-SOH formation: implications for RTK-H2O2 signaling 
The importance of P-SOH signaling is best exemplified by the receptor tyrosine kinase 
(RTK) activation (Finkel, 2011; Paulsen et al., 2011; Sundaresan et al., 1995), thus we looked for 
the temporal correlation between P-SOH and P-SSH (Figure 5A). HeLa cells treated with 100 
ng/ml of epithelial growth factor (EGF) responded by a sharp rise in P-SOH within the first 5-15 
min that dropped back to basal values by 30 min (Figure 5B). P-SSH levels however, followed a 
phase shifted curve, with the levels initially dropping at 5 min and then reaching a maximum at 30 
min. This correlated well with the overexpression of all three H2S producing enzymes (Figure 
S4C).  
To confirm the interplay between of P-SOH and P-SSH, we pretreated cells with GYY4137 
(Figure 5C, Figure S5D) or with a mix of CSE and CBS inhibitors (propargylglycine and 
aminooxyacetic acid, Figure 5D, Figure S5E) for 30 min to either increase or decrease, 
respectively, the intracellular H2S and P-SSH levels. Pretreatment with GYY4137 indeed induced 
an increase of P-SSH, and upon EGF stimulation these levels continued to rise over 30 min, while 
P-SOH dropped, remaining low and unchanged (Figure 5C, Figure S5D). In contrast, the 
pharmacological inhibition of endogenous H2S production resulted in a sharp rise of P-SOH levels, 
peaking at 5 min, and being fully resolved at 15 min, presumably due to cysteine overoxidation, 
as P-SSH levels remained very low and unchanged (Figure 5D, Figure S5E). These results 
strongly suggested that persulfidation represents the innate mechanism that cells use to resolve 
signaling by sulfenylation. At the same time, as both labeling approaches use dimedone-based 
probes, these data confirmed once more that the dimedone switch method can distinguish P-SSH 
from P-SOH.  
 We then tested other RTK pathways. The treatment of human umbilical endothelial vein 
cells (HUVEC) with 40 ng/ml of vascular endothelial growth factor (VEGF) showed similar phase-
shift curves for P-SOH and P-SSH, with P-SOH peaking at 5 min and reverting back to basal levels 
already after 15 min, while P-SSH levels peaked at 15 min and stayed high even after 30 min 
(Figure 5E, Figure S4F). P-SSH increased ~ 9 times in cells exposed to VEGF for 15 min, in 
accordance with very high H2S production rate that these cells possess (Filipovic et al., 2018b; Lin 
et al., 2013). The treatment of neuroblastoma cells (SH-SY5Y) with insulin, produced again a 
distinct peak of P-SSH levels, with the peaking time and the intensity of change correlating directly 
with the dose of insulin (Figure 5F, Figure S4G). The kinetics of sulfenylation preceded the P-
SSH wave in a phase shifted manner (Figure S4H). Finally, we used WT and CSE-/- MEFs and 
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treated them with 100 ng/ml EGF. The temporal profile of P-SSH in WT was quite similar to that 
observed for HeLa cells and was inhibited in CSE-/- cells (Figure S4I,J). On the other hand, 
sulfenylation was much stronger in CSE-/- cells (Figure S4I,J). 
 Next, we turned our attention to understanding the biological relevance of these ostensible 
waves of persulfidation. EGF receptor activation is regulated by sulfenylation (Paulsen et al., 
2011) so we focused on understanding if and how persulfidation could control the duration of EGF 
signaling. We first looked for the persulfidation of EGFR using commercially available antibody 
microarray plates for the EGFR pathway. Pentaplicates of two different antibodies for EGFR 
showed a strong increase in EGFR persulfidation in HeLa cells treated with EGF for 30 min 
(Figure 5G). Persulfidation of EGFR had a functional effect on the downstream signaling. 
Phosphorylation of Y1068, activated by cysteine sulfenylation, was strongly impaired in 
GYY4137 pretreated HeLa cells (Figure 5H). Correspondingly, the activation of the EGF receptor 
monitored in live cells also revealed a stronger receptor activation in cells pretreated with CSE and 
CBS inhibitors (PG and AOAA), an effect that could be reduced by GYY4137 pretreatment 
(Figure 5I). Furthermore, the inhibition of H2S production to increase the half-life of EGFR 
sulfenylation caused a significant increase of extracellular signal-regulated kinase (ERK) 
phosphorylation even without EGF stimulation (Figure S4K). 
Many of the cysteine containing phosphatases important for EGFR signaling have been already 
shown to be sulfenylated (Paulsen et al., 2011). This is particularly true for PTEN, PTP1B and 
SHPTP2, which we now find to be persulfidated as well (Figure S4L). In addition, using the EGFR 
pathway antibody microarray, we also assessed the persulfidation status of kinases downstream of 
EGFR (Figure 5J, Supporting Data set 5). Numerous protein targets were identified with an 
increased persulfidation status upon exposure to EGF. It is interesting that besides actin, kinases 
involved in the regulation of cystoskeleton rearrangements and cell motility are particularly 
affected (Figure 5K, Figures S4M-R). Taken together these data suggest that the formation of 
protein persulfides represents a redox switch for controlling cellular signaling initiated by H2O2 




Figure 5. Waves of protein persulfidation in RTK signaling. 
(A) Schematic representation of the signaling events triggered by the epidermal growth factor receptor (EGFR) 
activation. Nox: NADPH oxidase; AQP: aquaporin.  
(B) HeLa cells treated with 100 ng/mL EGF for 5, 15, 30 or 60 min were analyzed for protein sulfenylation (using 
dimedone biotin and then streptavidin-488) and protein persulfidation (using dimedone switch method with Cy5 as a 
reporting molecule). (Right) In-gel fluorescence of P-SSH levels and Western blots for P-SOH levels. (Left) 
Quantification of P-SSH and P-SOH changed as a function of time of EGF exposure. n3. Values are presented as 
mean ± SD. 
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(C) Quantification of P-SSH and P-SOH changes as a function of time of EGF exposure in HeLa cells pretreated with 
100 M GYY4137 for 30 min prior the EGF treatment. n3. Values are presented as mean ± SD. 
(D) Quantification of P-SSH and P-SOH changes as a function of time of EGF exposure in HeLa cells pretreated with 
2 mM mixture of aminooxyacetic acid (AOAA) and propargylglycine (PG) (1:1) for 30 min prior the EGF treatment. 
n3. Values are presented as mean ± SD. 
(E) Quantification of P-SSH and P-SOH changes in human umbilical vein endothelial cells as a function of time of 
VEGF (40 ng/mL) exposure. n3. Values are presented as mean ± SD. 
(F) The effect of different insulin concentrations on P-SSH levels in neuroblastoma SHSY5Y cells as a function of 
time of insulin exposure.  
(G) Persulfidation of EGF receptor of HeLa cells treated with 100 ng/mL EGF for 30 min, detected by two different 
antibodies using antibody microarray slides. n = 2. 
(H) Time dependent phosphorylation of EGF receptor tyrosine 1068 (Y1068) as a response to 100 ng/mL EGF. HeLa 
cells were pretreated or not with 100 M GYY4137 for 2 h prior to exposure to EGF. n = 3. 
(I) Real-time measurement of EGF receptor activation in living cells recorded with xCELLigence RTCA DP system. 
HeLa cells were also pretreated with GYY4137 (100 µM, 30 min) or with 2 mM mixture of AOAA and PG (1:1, 30 
min). EGF receptor activation was initiated by the addition of 150 ng/mL EGF. 
(J) Antibody microarray analysis of persulfidation of different kinases involved in the EGF signaling. HeLa cells were 
treated with 100 ng/mL EGF for 30 min. n = 2 
(K) Schematic presentation of protein targets involved in actin remodeling, cytoskeleton regulation and cell motility, 
found to be persulfidated in cells treated with 100 ng/mL EGF for 30 min. 
 
Protein persulfidation as a rescuing path from cysteine hyperoxidation 
While protein sulfenylation (and even sulfinylation for some proteins) represents a signaling event, 
uncontrollable production of H2O2 or any of the reactive oxygen species would results in the 
cysteine hyperoxidation and loss of function (Figure 6A). Our initial hypothesis was that due to 
its small size, diffusibility and high production flux (Cuevasanta et al., 2012; Filipovic et al., 
2018b; Vitvitsky et al., 2012), H2S could react as the first line of cellular defense against cysteine 
hyperoxidation (Figure 6A). Formed persulfides would be much better nucleophiles than cysteines 
alone, and could scavenge (Cuevasanta et al., 2015) more of the damaging oxidants. Owing to 
their reducible S-S bond, the ensuing S-sulfocysteine should be readily reduced by disulfide 
reductases, such as thioredoxin (Trx) (Figure 6A) creating a rescue loop. This is indeed the case 
for one of the known substrates for Trx, 3′-phosphoadenosine-5′-phosphosulfate reductase (Palde 
and Carroll, 2015).  
To address the reversibility of persulfide oxidation, we used S-sulfocysteine (SSC) as a 
model system (Figure 6B). Incubation of human recombinant Trx with SSC at an equimolar ratio 
resulted in the complete oxidation of Trx, as observed by the leftward mass shift (m/z = -2), 
corresponding to the formation of a disulfide bond (Figure 6C). When the C32S mutant, which is 
catalytically inactive, was incubated with the same amount of SSC, no spectral change could be 
observed (Figure S5A); whilst incubation with the C35S mutant, which initially reacts with the 
substrate but cannot complete the catalytic cycle, resulted in the characterization of the disulfide 
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adduct of Trx with cysteine (Figure 6D, Figure S5B). Spectrofluorometric kinetic analysis of the 
reaction (Figure 6E, S5C) derived an estimated rate constant of 6.1 ± 0.2 x 104 M-1 s-1, one order 
of magnitude faster than the reaction with cysteine persulfide and two orders of magnitude faster 
than the reaction with cystine (Wedmann et al., 2016). Coupled with thioredoxin reductase (TrxR), 
the reaction was also faster than with cystine (Figure S5D). Thioredoxin-related protein (TRP14) 
however, was not as efficient in cleaving SSC as human Trx (Figure S5E).  
We then assessed how persulfidation levels of different living systems correlate with their 
ability to resist stress. CSE-/- MEFs showed slower growth when compared to the wildtype cells 
and were much more sensitive to H2O2 (Figure 6F). Saccharomyces cerevisiae proved to be no 
exception either. Despite a slightly different cysteine and H2S metabolism (Figure S5F), the cys3 
(CSE) Saccharomyces cerevisiae mutant showed growth retardation (Figure S5G), had lower P-
SSH levels (Figure S5H), lower H2S levels (Figure S5I) and was more sensitive to H2O2 than the 
wild type (Figure 6G,H, Figure S5J). cys4 (CBS), on the other hand, exhibited somewhat higher 
H2S and P-SSH levels and therefore was more resistant to H2O2. 
We also tested the sensitivity of C. elegans to different ROS-inducing stressors. cth-1 and 
mpst-3 C. elegans mutants showed enhanced sensitivity to paraquat (Figure 6I) with ~50% of cth-
1 animals dead within 4 hr of exposure (compared to ~80% alive for N2). Another ROS stressor, 
sodium arsenite, also proved to be more toxic to cth-1 mutants compared to N2 (Figure 6J). 
Enhanced sensitivity of cth-1 to paraquat and arsenite could be rescued by pretreatment with H2S 
donors to increase the intracellular P-SSH levels (Figure 6K, Figure S5K, L). Even the N2 showed 
better survival after exposure to paraquat or arsenite, just by a 3 hr pretreatment with either 
GYY4137 or AP39 (Figure S5K, L).  
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Figure 6. Cytoprotective effects of protein persulfidation. 
(A) The proposed mechanism for the protective effects of protein persulfidation. Trx-thioredoxin, TrxR-thioredoxin 
reductase.  
(B) Model reaction of S-sulfocysteine (SSC) with human thioredoxin (hTrx). 
(C) Deconvoluted MS spectrum of 10 µM human recombinant Trx (black) and Trx treated with 10 µM S-sulfocysteine 
(SSC).  
(D) Deconvolution of mass spectra of 10 μM C35S Trx before (black) and after (red) the reaction with 10 μM SSC 
showing appearance of TrxS-S-Cys adduct in sample treated with SSC. 
(E) Plot of kobs vs. concentration of SSC for the reaction with human recombinant Trx. Reaction was followed 
fluorometrically by measuring conformational changes induced in Trx due to the cysteine oxidation.  
(F) Toxicity of H2O2 in WT and CSE-/- MEFs. Values presented as mean± S.D. n = 3. 
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(G-H) Flow cytometry analysis of cell death using propidium iodide (FL2A channel). Different yeast strains were 
grown to reach the stationary phase and then exposed to H2O2. Upper left quadrant was used as a measure of dead 
cells. 150000 cells were analysed per measurement. n=3. 
(I-J) Survival curves of N2, cth-1 and mpst-3 C. elegans strains exposed to 60 mM paraquat (I) and 5 mM sodium 
arsenite (J). N>80 worms. Experiments were performed in triplicate.  
(K) The effect of short-term (3h) pre-exposure to GYY4137 (500 µM) or AP39 (100 nM) on survival rate of cth-1 C. 
elegans mutants treated with 60 mM paraquat. N>80 worms. Experiments were performed in triplicate.  
 
 
Protein persulfidation decreases with aging 
With aging there is an imbalance between ROS production and removal, resulting in an increase 
in oxidative damage (Balaban et al., 2005; Finkel and Holbrook, 2000; Liochev, 2013; Redman et 
al., 2018). Moreover, two independent quantitative proteomics studies found that in C. elegans, 
CSE is decreased during aging (Aging et al., 2015; Narayan et al., 2016). Here we tested the 
hypothesis that protective pools of intracellular P-SSH decline with age and correlate with the 
lifespan of individuals within a given species. While the cth-1 C. elegans mutants did not display 
an overall significantly shorter median/maximal life span, they initially exhibited a much higher 
death rate (Figure S6A). Mpst-3 mutants, which had an even lower P-SSH pool (Figure 3G), lived 
significantly shorter (Figure S6A). Additionally, the persulfidation levels in wild type N2 worms 
gradually decreased from day 1 to day 7 of adulthood (Figure S6B). To confirm the evolutionary 
conservation of this phenomenon, we looked at Wistar rats of 1, 3, 6, 12, and 24 months of age. In 
brain extracts, reduced protein persulfidation levels were observed beginning at 6 months of age, 
with an approximately 50% lower persulfidation in 24-month-old rats relative to 1-month-old rats 
(Figure 7A). The reduction of P-SSH correlated with the loss of protein expression of all three 
H2S producing enzymes (Figure 7B, Figure S6C). We also observed a profound decrease in 
protein persulfidation and H2S-generating enzyme levels (CSE, 3MST) in rat hearts as a function 
of age (Figure 7C), while in liver P-SSH and CSE and CBS levels trended lower but were not 
significantly different between 12 and 24 month old mice, (Figure S6D). 
Finally, as a proof-of-concept experiment we analyzed the persulfidation and sulfinylation 
levels in human fibroblasts originating from the same individual but collected at different ages (31 
and 48 years of age). The results displayed a decrease in P-SSH levels and an increase in P-SO2H 
(Figure 7D) in accordance with our hypothesis (Figure 6A).  
Life-span extension by dietary restriction is caused by increased protein persulfidation 
Recent studies suggest that dietary restriction (DR) increases endogenous H2S production (Hine et 
al., 2015; Mitchell et al., 2016) and that this increase is associated with multiple DR benefits 
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including extended longevity in different species. However, the mechanism by which H2S 
contributes to DR benefits remains poorly characterized. We tested the hypothesis that DR 
increases longevity in part by increasing protein persulfidation. We started with C. elegans by 
using the eat-2 genetic model of DR which eat less and live longer than N2 controls. Additional 
deletion of either cth-1 or mpst-3 reduced the lifespan of eat-2 mutant back to control levels 
(Figure 7E). Interestingly, this was in excellent concordance with the total P-SSH pool in these 
worms; eat-2 mutants had approximately 3 times higher P-SSH levels than N2, while double 
mutants had P-SSH levels close to or even lower than N2 (Figure 7F). Furthermore, lifespan 
extension induced by 2-deoxy-D-glucose (DOG) treatment in wildtype N2 worms was completely 
reversed in cth-1 and mpst-3 mutants (Figure 7G). 
 We next looked at 7 and 20 month old C57BL/6J mice fed ad libitum (AL) or subject to 
daily 30% calorie restricted (CR) from the age of 2 months. Liver persulfidation levels declined 
with age, but were higher in both CR groups compared to AL (Figure 7H).  
 Furthermore, we monitored changes in persulfidation of young and old mice (2 vs 12 
month-old) challenged with i.p. glucose injection. The wave of persulfidation was observed in the 
muscle tissue of the young mice that was blunted in the 12 month-old animals (Figure 7I), 
confirming the waves observed in cells treated with insulin (Figure 5F). Lower persulfidation in 
old mice as well as the decrease of the H2S producing enzymes could be confirmed on yet another 
model system (Figure S6E). 
Finally, we tested whether pharmacological interventions to increase persulfidation levels 
could extend lifespan. While many H2S donors have shown considerable pre-clinical efficacy and 
are currently undergoing clinical evaluation (Wallace and Wang, 2015), we opted for testing an 
established FDA approved therapeutic drug, sodium thiosulfate, which does not release H2S itself 
but exhibits beneficial effects mimicking those of H2S (Snijder et al., 2015). We observed that 
treatment of cell lysates with either thiosulfate, TST or both increased the persulfidation levels 
several fold (Figure S6F). C. elegans grown on medium supplemented with 1 mM thiosulfate 
showed higher persulfidation levels (Figure 7J) as such, we opted for testing its effect on lifespan. 
Indeed, worms grown on medium supplemented with 1 mM thiosulfate had a significant increase 




Figure 7. Anti-aging properties of protein persulfidation. 
(A) Changes in the persulfidation levels in brain extracts from Wistar rats 1, 3, 6, 12 and 24 months of age. Values 
are presented as mean ± S.D. n = 3/age group. 
(B) Immunohistochemical analysis of CSE, CBS and MST expression levels in the cortex of 1, 12 and 24 month old 
male Wistar rats. Images are representative of 3 animals per experimental group, magnification 20x. 
(C) Protein persulfidation levels of 1, 12 and 24 month old hearts of male Wistar rats (top). Expression levels of CSE, 
CBS and MPST in hearts of 1,6, 12 and 24 month old male Wistar rats (bottom). Images are representative of 3 animals 
per experimental group. 
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(D) PSSH and PSO2H levels (marked on y axis as PSX) in human fibroblasts originating from the same donor but 
collected at the age of 31 and 48.  
(E) Survival curves for N2, eat-2, eat-2;cth-1 and eat-2; mpst-3 double mutants. n > 100 per each line.  
(F) Persulfidation levels in N2, eat-2, eat-2;cth-1 and eat-2; mpst-3 C. elegans mutants. For the fluorescence in-gel 
detection, P-SSH levels were calculated as a ratio of Cy5/488 fluorescence readouts. Values are presented as average 
± S.D. Protein extracts from ~16000 worms were used for each lane. Experiments were performed in triplicates.  
(G) Survival curves for N2 and cth-1 mutants grown in the absence or presence of 5 mM 2-deoxy-D-glucose (DOG). 
n = 100 per each line.  
(H) Age-induced persulfidation changes in mice fed ad libitum and mice fed with calorie restriction diet. Values are 
presented as mean ± S.D. n=5 
(I) Time-dependent PSSH changes in the muscle tissue of mice injected i.p. with D-glucose (2 g/kg body weight). 
Values are presented as mean ± S.D. n  3. 
(J) Persulfidation levels in N2 worms before and after the treatment with 1 mM thiosulfate. Values are presented as 
mean ± S.D.  
(K) Survival curves for N2 C. elegans, and N2 treated with 1 mM thiosulfate. n > 160 per group. 
 
DISCUSSION 
Versatility and selectivity of dimedone switch method 
By combining commercially available and well-characterized chemicals, our novel dimedone 
switch method is a simple and robust approach for selectively labeling protein persulfides, that 
enables the installation of various groups to proteins and the use of a wide range of detection 
methods. Moreover, our chemical method allows for a wide scale analysis of metabolic pathways 
that could be controlled by persulfidation and the identification of new redox switches. The 
constant green fluorescence introduced by the NBF-Cl probe provides not only the information 
about total load but could also be explored for high-throughput screening. It is easy to envision a 
setup where by measuring only the green fluorescence in microplates with immobilized 
neutravidin, total persulfidation labeled with DCP-Bio1 could be screened. The versatility of 
dimedone based probes also permits site-centric identification and quantitation of persulfides by 
MS, as done for protein sulfenylation (Yang et al., 2014). The installation of different fluorophores 
through CuAAC and almost undetectable unselective background in microscopic analysis also 
carries a potential for further exploration of protein persulfidation in tissue sections. Finally, the 
use of simple in-gel detection prevents all the problems associated with column separation and 
Western blot transfer, commonly used in other persulfide detection methods (Dóka et al., 2016). 
Protein persulfidation is controlled by transsulfuration pathway and cysteine catabolism 
From the data presented here, we conclude that protein persulfidation is almost exclusively 
controlled by the three H2S producing enzymes involved in the transsulfuration pathway and 
cysteine catabolism (Figure 3A). This is evident in all tested life forms. However, in mammalian 
cells and under basal substrate availability (assuming that all 3 enzymes are present in the cell), 
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CSE is expected to be the major source of H2S (Filipovic et al., 2018b). CBS would predominantly 
be involved in cystathionine production while the activity of MPST would depend on thioredoxin 
availability and CAT activity (Figure 3A). MPST could nonetheless play a significant role in 
controlling protein persulfidation given that D-cysteine causes a dramatic increase in protein 
persulfidation representing an interesting venue for drug development.  
Persulfidation as integral part of H2O2 signaling or/and as evolutionary conserved route to rescue 
cysteines 
As life emerged in an H2S-enriched environment (Olson and Straub, 2016) and in under 
conditions of extensive radiation where ROS were formed by photolysis of water (Liang et al., 
2006), protection of cysteine residues was necessitated. The formation of persulfides poses as the 
simplest answer. In persulfides, sulfur atoms are oxidized, however concurrently sulfur is 
deprotonated and highly nucleophilic, reducing ROS at least one order of magnitude faster than its 
corresponding thiolate (Cuevasanta et al., 2015; Filipovic et al., 2018b). In other words, while a 
cysteine gets oxidized to form a persulfide, it forms a strong reducing agent at the same time.  
H2O2 as main ROS player is now widely accepted as a signaling molecule (D’Autréaux 
and Toledano, 2007; Holmström and Finkel, 2014; Yang et al., 2014). This is best exemplified in 
the case of growth factor receptor signaling (Paulsen and Carroll, 2013; Sundaresan et al., 1995). 
Approximately 1000 cysteine sites have been found to be sulfenylated, raising the question of, 
how are these sites rescued? In our study, waves of persulfidation are observed following 
sulfenylation, as a response to RTK activation, confirming that persulfidation is an integral part of 
RTK signaling. A recent study demonstrated that a large number of proteins undergo further 
oxidation to sulfinic acid as well (Akter et al., 2018). Our results demonstrate that without 
H2S/persulfidation proteins undergo a substantial thiol oxidation (sulfenylation, sulfinylation and 
sulfonylation) even with H2O2 concentrations that cause no change in normal cells. This 
overlooked phenomenon questions whether and in which concentration range H2O2 acts as a 
signaling molecule without H2S.  
We demonstrate that as cells age their persulfidation levels decrease due to the loss of H2S 
producing enzymes. Reacting with ROS, a persulfide will form a S-sulfonate which we show could 
be readily reduced back to a thiolate by thioredoxin. This rescue loop for preserving cysteine 
residues in proteins and preventing their loss of function is probably an evolutionary remnant used 
as a general protective mechanism in all life forms. This is best documented by the enhanced 
 27 
sensitivity of different life forms with low P-SSH levels to oxidant stressors and their increased 
resistance once the intracellular P-SSH pool is increased even by a short-term pretreatment with 
H2S donors. This unifying mechanism explains the beneficial effects of dietary restriction, already 
known to result in H2S overproduction (Hine et al., 2015), as well as lifespan extension caused by 
pharmacological increase of protein persulfidation. Thus, our results further strengthen the ROS 
theory of aging (Redman et al., 2018). 
It is worth mentioning that beside a general protection, persulfidation of specific proteins 
could result in alteration of their function (Filipovic et al., 2018b; Paul and Snyder, 2015; Vandiver 
et al., 2013), as we observe in the case of MnSOD, whose activity is preserved after persulfidation. 
It is possible that DR-induced decrease of ROS (Redman et al., 2018) could also be partially related 
to better activity of ROS removing enzymes.  
Beside aging, general protective effects of protein persulfidation could be translated to 
many other disease states. HD and neurodegeneration are strongly linked to CSE expression and 
pharmacological interventions to increase CSE levels, such as monensin treatment, show 
promising therapeutic effects (Paul et al., 2014; Sbodio et al., 2016, 2018). Decreased 
persulfidation in HD cells and increased P-SSH levels by upregulating CSE expression reported 
in our study could provide a general explanation for this. Taken together, our data represent a good 
starting point for the fine tuning of targeted therapeutic approaches to increase health and lifespan. 
 
REFERENCES 
Aging, C., Walther, D.M., Kasturi, P., Mann, M., Hartl, F.U., Walther, D.M., Kasturi, P., Zheng, 
M., Pinkert, S., Vecchi, G., et al. (2015). Article Widespread Proteome Remodeling and 
Aggregation in Aging C . elegans. Cell 161, 919–932. 
Akaike, T., Ida, T., Wei, F.Y., Nishida, M., Kumagai, Y., Alam, M.M., Ihara, H., Sawa, T., 
Matsunaga, T., Kasamatsu, S., et al. (2017). Cysteinyl-tRNA synthetase governs cysteine 
polysulfidation and mitochondrial bioenergetics. Nat. Commun. 8, 1177. 
Akter, S., Fu, L., Jung, Y., Conte, M. Lo, Lawson, J.R., Lowther, W.T., Sun, R., Liu, K., Yang, 
J., and Carroll, K.S. (2018). Chemical proteomics reveals new targets of cysteine sulfinic acid 
reductase. Nat. Chem. Biol. 14, 995–1004. 
Alexander, B.E., Coles, S.J., Fox, B.C., Khan, T.F., Maliszewski, J., Perry, A., Pitak, M.B., 
 28 
Whiteman, M., Wood, M.E., Nakashima, I., et al. (2015). Investigating the generation of 
hydrogen sulfide from the phosphonamidodithioate slow-release donor GYY4137. Med. Chem. 
Commun. 6, 1649–1655. 
Artaud, I., and Galardon, E. (2014). A persulfide analogue of the nitrosothiol SNAP: formation, 
characterization and reactivity. Chembiochem 15, 2361–2364. 
Balaban, R.S., Nemoto, S., and Finkel, T. (2005). Mitochondria, Oxidants, and Aging. Cell 120, 
483–495. 
Bernal-Perez, L.F., Prokai, L., and Ryu, Y. (2012). Selective N-terminal fluorescent labeling of 
proteins using 4-chloro-7-nitrobenzofurazan: A method to distinguish protein N-terminal 
acetylation. Anal. Biochem. 428, 13–15. 
Blackstone, E. (2005). H2S Induces a Suspended Animation-Like State in Mice. Science (80-. ). 
308, 518–518. 
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71–94. 
Crouzet, M., Claverol, S., Lomenech, A.M., Le Sénéchal, C., Costaglioli, P., Barthe, C., Garbay, 
B., Bonneu, M., and Vilain, S. (2017). Pseudomonas aeruginosa cells attached to a surface 
display a typical proteome early as 20 minutes of incubation. PLoS One 12, e0180341. 
Cuevasanta, E., Denicola, A., Alvarez, B., and Möller, M.N. (2012). Solubility and Permeation 
of Hydrogen Sulfide in Lipid Membranes. PLoS One 7, e34562. 
Cuevasanta, E., Lange, M., Bonanata, J., Coitiño, E.L., Ferrer-Sueta, G., Filipovic, M.R., and 
Alvarez, B. (2015). Reaction of Hydrogen Sulfide with Disulfide and Sulfenic Acid to Form the 
Strongly Nucleophilic Persulfide. J. Biol. Chem. 290, 26866–26880. 
D’Autréaux, B., and Toledano, M.B. (2007). ROS as signalling molecules: Mechanisms that 
generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813–824. 
Delobel, J., Prudent, M., Crettaz, D., ElHajj, Z., Riederer, B.M., Tissot, J.D., and Lion, N. 
(2016). Cysteine redox proteomics of the hemoglobin-depleted cytosolic fraction of stored red 
blood cells. Proteomics - Clin. Appl. 10, 883–893. 
Dóka, É., Pader, I., Bíró, A., Johansson, K., Cheng, Q., Ballagó, K., Prigge, J.R., Pastor-Flores, 
D., Dick, T.P., Schmidt, E.E., et al. (2016). A novel persulfide detection method reveals protein 
persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems. Sci. Adv. 
 29 
2, e1500968. 
Ellis, H.R., and Poole, L.B. (1997). Novel application of 7-chloro-4-nitrobenzo-2-oxa-1,3-
diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide 
reductase. Biochemistry 36, 15013–15018. 
Fernandez-Caggiano, M., Schröder, E., Cho, H.J., Burgoyne, J., Barallobre-Barreiro, J., Mayr, 
M., and Eaton, P. (2016). Oxidant-induced interprotein disulfide formation in cardiac protein DJ-
1 occurs via an interaction with peroxiredoxin 2. J. Biol. Chem. 291, 10399–10410. 
Filipovic, M.R., Miljkovic, J., Allgäuer, A., Chaurio, R., Shubina, T., Herrmann, M., and 
Ivanovic-Burmazovic, I. (2012). Biochemical insight into physiological effects of H₂ S: reaction 
with peroxynitrite and formation of a new nitric oxide donor, sulfinyl nitrite. Biochem. J. 441, 
609–621. 
Filipovic, M.R., Zivanovic, J., Alvarez, B., and Banerjee, R. (2018a). Chemical Biology of H 2 S 
Signaling through Persulfidation. Chem. Rev. 118, 1253–1337. 
Filipovic, M.R., Zivanovic, J., Alvarez, B., and Banerjee, R. (2018b). Chemical Biology of H2S 
Signaling through Persulfidation. Chem. Rev. 118, 1253–1337. 
Finkel, T. (2011). Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7–15. 
Finkel, T., and Holbrook, N.J. (2000). Oxidants, oxidative stress and the biology of ageing. 
Nature 408, 239–247. 
Foster, M.W., Hess, D.T., and Stamler, J.S. (2009). Protein S-nitrosylation in health and disease: 
a current perspective. Trends Mol. Med. 15, 391–404. 
Furdui, C.M., and Poole, L.B. (2014). Chemical approaches to detect and analyze protein 
sulfenic acids. Mass Spectrom. Rev. 33, 126–146. 
Hearn, A.S., Stroupe, M.E., Cabelli, D.E., Lepock, J.R., Tainer, J.A., Nick, H.S., and Silverman, 
D.N. (2001). Kinetic analysis of product inhibition in human manganese superoxide dismutase. 
Biochemistry 40, 12051–12058. 
Hine, C., Harputlugil, E., Zhang, Y., Ruckenstuhl, C., Lee, B.C., Brace, L., Longchamp, A., 
Treviño-Villarreal, J.H., Mejia, P., Ozaki, C.K., et al. (2015). Endogenous Hydrogen Sulfide 
Production Is Essential for Dietary Restriction Benefits. Cell 160, 132–144. 
Holmström, K.M., and Finkel, T. (2014). Cellular mechanisms and physiological consequences 
 30 
of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15, 411–421. 
Klomsiri, C., Nelson, K.J., Bechtold, E., Soito, L., Johnson, L.C., Lowther, W.T., Ryu, S.-E., 
King, S.B., Furdui, C.M., and Poole, L.B. (2010). Use of dimedone-based chemical probes for 
sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-
sensitive proteins. Methods Enzymol. 473, 77–94. 
Liang, M.-C., Hartman, H., Kopp, R.E., Kirschvink, J.L., and Yung, Y.L. (2006). Production of 
hydrogen peroxide in the atmosphere of a Snowball Earth and the origin of oxygenic 
photosynthesis. Proc. Natl. Acad. Sci. 18896–18899. 
Lin, V.S., Lippert, A.R., and Chang, C.J. (2013). Cell-trappable fluorescent probes for 
endogenous hydrogen sulfide signaling and imaging H2O2-dependent H2S production. Proc. 
Natl. Acad. Sci. 110, 7131–7135. 
Liochev, S.I. (2013). Reactive oxygen species and the free radical theory of aging. Free Radic. 
Biol. Med. 60, 1–4. 
Liu, H.C., Chen, W.S., Chiang, C.M., Shia, B.C., and Ju, J.M. (2015). Extending Liu???s 
ordering theory for cognitive diagnosis and remedial instruction. ICIC Express Lett. Part B Appl. 
6, 491–496. 
Marino, S.M., and Gladyshev, V.N. (2010). Cysteine Function Governs Its Conservation and 
Degeneration and Restricts Its Utilization on Protein Surfaces. J. Mol. Biol. 404, 902–916. 
Markó, L., Szijártó, I.A., Filipovic, M.R., Kaßmann, M., Balogh, A., Park, J.-K., Przybyl, L., 
N’diaye, G., Krämer, S., Anders, J., et al. (2016). Role of Cystathionine Gamma-Lyase in 
Immediate Renal Impairment and Inflammatory Response in Acute Ischemic Kidney Injury. Sci. 
Rep. 6, 27517. 
Matsuda, Y., Higashiyama, S., Kijima, Y., Suzuki, K., Kawano, K., Akiyama, M., Kawata, S., 
Tarui, S., Deutsch, H.F., and Taniguchi, N. (1990). Human liver manganese superoxide 
dismutase: Purification and crystallization, subunit association and sulfhydryl reactivity. Eur. J. 
Biochem. 194, 713–720. 
Mitchell, S.J., Madrigal-Matute, J., Scheibye-Knudsen, M., Fang, E., Aon, M., González-Reyes, 
J.A., Cortassa, S., Kaushik, S., Gonzalez-Freire, M., Patel, B., et al. (2016). Effects of Sex, 
Strain, and Energy Intake on Hallmarks of Aging in Mice. Cell Metab. 23, 1093–1112. 
Mustafa, A.K., Gadalla, M.M., Sen, N., Kim, S., Mu, W., Gazi, S.K., Barrow, R.K., Yang, G., 
 31 
Wang, R., and Snyder, S.H. (2009). H2S Signals Through Protein S-Sulfhydration. Sci. Signal. 
2, ra72–ra72. 
Narayan, V., Ly, T., Pourkarimi, E., Murillo, A.B., Gartner, A., Lamond, A.I., and Kenyon, C. 
(2016). Deep Proteome Analysis Identifies Age-Related Processes in C. elegans. Cell Syst. 3, 
144–159. 
Olson, K.R., and Straub, K.D. (2016). The Role of Hydrogen Sulfide in Evolution and the 
Evolution of Hydrogen Sulfide in Metabolism and Signaling. Physiology 31, 60–72. 
Ono, K., Akaike, T., Sawa, T., Kumagai, Y., Wink, D.A., Tantillo, D.J., Hobbs, A.J., Nagy, P., 
Xian, M., Lin, J., et al. (2014). Redox chemistry and chemical biology of H2S, hydropersulfides, 
and derived species: implications of their possible biological activity and utility. Free Radic. 
Biol. Med. 77, 82–94. 
Palde, P.B., and Carroll, K.S. (2015). A universal entropy-driven mechanism for thioredoxin–
target recognition. Proc. Natl. Acad. Sci. 112, 7960–7965. 
Pan, J., and Carroll, K.S. (2013). Persulfide reactivity in the detection of protein S-sulfhydration. 
ACS Chem. Biol. 8, 1110–1116. 
Pasini, E.M., Kirkegaard, M., Mortensen, P., Lutz, H.U., Thomas, A.W., and Mann, M. (2006). 
In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108, 791–
801. 
Patel, B.H., Percivalle, C., Ritson, D.J., Duffy, C.D., and Sutherland, J.D. (2015). Common 
origins of RNA, protein and lipid precursors in a cyanosulfidic protometabolism. Nat. Chem. 7, 
301–307. 
Paul, B.D., and Snyder, S.H. (2012). H2S signalling through protein sulfhydration and beyond. 
Nat. Rev. Mol. Cell Biol. 13, 499–507. 
Paul, B.D., and Snyder, S.H. (2015). H2S: A Novel Gasotransmitter that Signals by 
Sulfhydration. Trends Biochem. Sci. 40, 687–700. 
Paul, B.D., Sbodio, J.I., Xu, R., Vandiver, M.S., Cha, J.Y., Snowman, A.M., and Snyder, S.H. 
(2014). Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease. 
Nature 509, 96–100. 
Paulsen, C.E., and Carroll, K.S. (2013). Cysteine-mediated redox signaling: chemistry, biology, 
 32 
and tools for discovery. Chem. Rev. 113, 4633–4679. 
Paulsen, C.E., Truong, T.H., Garcia, F.J., Homann, A., Gupta, V., Leonard, S.E., and Carroll, 
K.S. (2011). Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase 
activity. Nat. Chem. Biol. 8, 57–64. 
Pol, A., Renkema, G.H., Tangerman, A., Winkel, E.G., Engelke, U.F., de Brouwer, A.P.M., 
Lloyd, K.C., Araiza, R.S., van den Heuvel, L., Omran, H., et al. (2018). Mutations in 
SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis. Nat. 
Genet. 50, 120–129. 
Poole, L.B., Karplus, P.A., and Claiborne, A. (2004). Protein sulfenic acids in redox signaling. 
Annu. Rev. Pharmacol. Toxicol. 44, 325–347. 
Redman, L.M., Smith, S.R., Burton, J.H., Martin, C.K., Il’yasova, D., and Ravussin, E. (2018). 
Metabolic Slowing and Reduced Oxidative Damage with Sustained Caloric Restriction Support 
the Rate of Living and Oxidative Damage Theories of Aging. Cell Metab. 27, 805-815.e4. 
Reisz, J.A., Bechtold, E., King, S.B., Poole, L.B., and Furdui, C.M. (2013). Thiol-blocking 
electrophiles interfere with labeling and detection of protein sulfenic acids. FEBS J. 280, 6150–
6161. 
Sbodio, J.I., Snyder, S.H., and Paul, B.D. (2016). Transcriptional control of amino acid 
homeostasis is disrupted in Huntington’s disease. Proc. Natl. Acad. Sci. 113, 8843–8848. 
Sbodio, J.I., Snyder, S.H., and Paul, B.D. (2018). Golgi stress response reprograms cysteine 
metabolism to confer cytoprotection in Huntington’s disease. Proc. Natl. Acad. Sci. U S A 115, 
780–785. 
Seo, Y.H., and Carroll, K.S. (2009). Profiling protein thiol oxidation in tumor cells using sulfenic 
acid-specific antibodies. Proc. Natl. Acad. Sci. U. S. A. 106, 16163–16168. 
Shibuya, N., Koike, S., Tanaka, M., Ishigami-Yuasa, M., Kimura, Y., Ogasawara, Y., Fukui, K., 
Nagahara, N., and Kimura, H. (2013). A novel pathway for the production of hydrogen sulfide 
from D-cysteine in mammalian cells. Nat. Commun. 4, 1366. 
Snijder, P.M., Baratashvili, M., Grzeschik, N.A., Leuvenink, H.G.D., Kuijpers, L., Huitema, S., 
Schaap, O., Giepmans, B.N.G., Kuipers, J., Miljkovic, J.L., et al. (2015). Overexpression of 
cystathionine γ-lyase suppresses detrimental effects of spinocerebellar ataxia type 3. Mol. Med. 
21, 758. 
 33 
Stiernagle, T. (2006). Maintenance of C. elegans. WormBook 1–11. 
Sulston, J., and Hodgkin, J. (1988). Methods, The Nematode Caenorhabditis elegans. In Cold 
Spring Harbor Monograph Archive, W. Wood, ed. pp. 587–606. 
Sundaresan, M., Yu, Z.-X., Ferrans, V.J., Irani, K., and Finkel, T. (1995). Requirement for 
Generation of H(2)O(2) for Platelet-Derived Growth Factor Signal Tran sduction. Science (80-. 
). 270, 296–299. 
Szabó, C. (2007). Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 
917–935. 
Szabó, C., Ischiropoulos, H., and Radi, R. (2007). Peroxynitrite: Biochemistry, pathophysiology 
and development of therapeutics. Nat. Rev. Drug Discov. 6, 662–680. 
Szczesny, B., Módis, K., Yanagi, K., Coletta, C., Le Trionnaire, S., Perry, A., Wood, M.E., 
Whiteman, M., and Szabo, C. (2014). AP39, a novel mitochondria-targeted hydrogen sulfide 
donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss 
of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide 41, 
120–130. 
Tandon, S., and Horowitz, P.M. (1989). Reversible folding of rhodanese. Presence of 
intermediate(s) at equilibrium. J. Biol. Chem. 264, 9859–9866. 
Le Trionnaire, S., Perry, A., Szczesny, B., Szabo, C., Winyard, P.G., Whatmore, J.L., Wood, 
M.E., and Whiteman, M. (2014). The synthesis and functional evaluation of a mitochondria-
targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-
yl)phenoxy)decyl)triphenylphosphonium bromide (AP39). Med. Chem. Commun. 5, 728–736. 
Valentine, W.N., Toohey, J.I., Paglia, D.E., Nakatani, M., and Brockway, R.A. (1987). 
Modification of erythrocyte enzyme activities by persulfides and methanethiol: possible 
regulatory role. Proc. Natl. Acad. Sci. U. S. A. 84, 1394–1398. 
Vandiver, M.S., Paul, B.D., Xu, R., Karuppagounder, S., Rao, F., Snowman, A.M., Seok Ko, H., 
Il Lee, Y., Dawson, V.L., Dawson, T.M., et al. (2013). Sulfhydration Mediates Neuroprotective 
Actions of Parkin. Nat. Commun. 4, 1626. 
Vitvitsky, V., Kabil, O., and Banerjee, R. (2012). High Turnover Rates for Hydrogen Sulfide 
Allow for Rapid Regulation of Its Tissue Concentrations. Antioxid. Redox Signal. 17, 22–31. 
 34 
Wallace, J.L., and Wang, R. (2015). Hydrogen sulfide-based therapeutics: exploiting a unique 
but ubiquitous gasotransmitter. Nat. Rev. Drug Discov. 14, 329–345. 
Wang, R. (2012). Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That 
Blossomed. Physiol. Rev. 92, 791–896. 
Wedmann, R., Bertlein, S., Macinkovic, I., Böltz, S., Miljkovic, J.L., Muñoz, L.E., Herrmann, 
M., and Filipovic, M.R. (2014). Working with “H2S”: Facts and apparent artifacts. Nitric Oxide 
41, 85–96. 
Wedmann, R., Onderka, C., Wei, S., Szijártó, I.A., Miljkovic, J.L., Mitrovic, A., Lange, M., 
Savitsky, S., Yadav, P.K., Torregrossa, R., et al. (2016). Improved tag-switch method reveals 
that thioredoxin acts as depersulfidase and controls the intracellular levels of protein 
persulfidation. Chem. Sci. 7, 3414–3426. 
Wood, Z.A., Poole, L.B., and Karplus, P.A. (2003). Peroxiredoxin evolution and the regulation 
of hydrogen peroxide signaling. Science (80-. ). 300, 650–653. 
Yadav, P.K., Yamada, K., Chiku, T., Koutmos, M., and Banerjee, R. (2013). Structure and 
Kinetic Analysis of H2S Production by Human Mercaptopyruvate Sulfurtransferase. J. Biol. 
Chem. 288, 20002–20013. 
Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A.K., Mu, W., Zhang, 
S., et al. (2008). H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of 
Cystathionine -Lyase. Science (80-. ). 322, 587–590. 
Yang, G., Zhao, K., Ju, Y., Mani, S., Cao, Q., Puukila, S., Khaper, N., Wu, L., and Wang, R. 
(2013). Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and 
activation of Nrf2. Antioxid. Redox Signal. 18, 1906–1919. 
Yang, H.Y., Kwon, J., Choi, H.I., Park, S.H., Yang, U., Park, H.R., Ren, L., Chung, K.J., Kim, 
Y.U., Park, B.J., et al. (2012). In-depth analysis of cysteine oxidation by the RBC proteome: 
Advantage of peroxiredoxin II knockout mice. Proteomics 12, 101–112. 
Yang, J., Gupta, V., Carroll, K.S., and Liebler, D.C. (2014). Site-specific mapping and 
quantification of protein S-sulphenylation in cells. Nat. Commun. 5, 4776. 
Zaccarin, M., Falda, M., Roveri, A., Bosello-Travain, V., Bordin, L., Maiorino, M., Ursini, F., 
and Toppo, S. (2014). Quantitative label-free redox proteomics of reversible cysteine oxidation 
in red blood cell membranes. Free Radic. Biol. Med. 71, 90–98. 
 35 
Zhang, D., Macinkovic, I., Devarie-Baez, N.O., Pan, J., Park, C.-M., Carroll, K.S., Filipovic, 
M.R., and Xian, M. (2014). Detection of Protein S-Sulfhydration by a Tag-Switch Technique. 
Angew. Chemie Int. Ed. 53, 575–581. 
Zhang, J., Xin, L., Shan, B., Chen, W., Xie, M., Yuen, D., Zhang, W., Zhang, Z., Lajoie, G.A., 
and Ma, B. (2012). PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive 
and Accurate Peptide Identification. Mol. Cell. Proteomics 11, M111.010587. 
 
Acknowledgments: The authors would like to thank Dr Michel Toledano for careful reading of 
the manuscript and helpful discussions, and Bertrand Daignan-Fornier for his help with yeast 
experiments. Funding: This work was supported by the ATIP-Avenir grant, by the French State 
in the frame of the ‘Investments for the future’ Programme IdEx Bordeaux (ANR-10-IDEX-03-
02) and by FRM. MW acknowledges support from MRC, UK (MR/M022706/1) and The Brian 
Ridge Scholarship (to RT).  MM and VM were supported by the Ministry of Education, Science 
and Technology Development of the Republic of Serbia (173009). GS and JBK acknowledge 
support by the DFG, Germany (CRC1218).  Competing interests: MW and the University of 
Exeter have patents on the therapeutic and agricultural use of mitochondria-targeted, and other, 
hydrogen sulfide delivery molecules. All other authors declare no competing interests.  
Authors contribution: JZ and EK contributed equally to this study and performed most of the 
experiments. MRF conceived the study. JK, BA, SS-R, DT, JLjM, BB, DP, MM, BP and MRF 
also performed experiments. YG, KC, RT, MW, MB, VM, II-B, GS, JEG, BGZ, BP and SHS 
provided tools and intellectual input, and helped with data analysis. SM and JM provided DR 












KEY RESOURCES TABLE  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies   
Anti-β-actin, mouse monoclonal Santa Cruz Biotechnology Cat# sc-47778 
Anti-β-tubulin, mouse monoclonal Sigma Aldrich Cat# T0198 
Anti-GAPDH, mouse monoclonal  Sigma Aldrich Cat# G8795 
Anti-HSP70, mouse monoclonal Abcam Cat# Ab5439 
Anti-KEAP1 P586, rabbit polyclonal Cell Signalling Cat# 4678 
Anti-eNOS, rabbit monoclonal Cell Signalling Cat# 32027 
Anti-Parkin, mouse monoclonal Santa Cruz Biotechnology Cat# sc-136989 
Anti-SOD-2, mouse monoclonal Santa Cruz Biotechnology Cat# sc-137254 
Anti-TST, rabbit polyclonal GeneTex Cat# GTX114858 
Anti-SQRDL, rabbit polyclonal Sigma Aldrich Cat# HPA017079 
Anti-PTEN, mouse monoclonal Santa Cruz Biotechnology Cat# sc-7974 
Anti-PTP1B, mouse monoclonal Santa Cruz Biotechnology Cat# sc-133259 
Anti-SH-PTP2, mouse monoclonal Santa Cruz Biotechnology Cat# sc-7384 
Anti-EGFR, rabbit polyclonal  Santa Cruz Biotechnology Cat# sc-03-G 
Anti-CBS, mouse monoclonal Santa Cruz Biotechnology Cat# sc-133154 
Anti-CBS, rabbit polyclonal Santa Cruz Biotechnology Cat# sc-67154 
Anti-MPST, rabbit polyclonal Sigma Aldrich Cat# HPA001240 
Anti-CTH, rabbit From Prof. Snyder’s lab (Johns 
Hopkins University School of 
Medicine) 
(Paul et al., 2014) 
Anti-CTH, mouse monoclonal Santa Cruz Biotechnology Cat# sc-365382 
Anti- p-ERK, mouse monoclonal Santa Cruz Biotechnology Cat# sc-7383 
Anti ERK 1, mouse monoclonal Santa Cruz Biotechnology Cat# sc-271269 
Anti-DJ-1, mouse monoclonal Santa Cruz Biotechnology Cat# sc-55572 
Anti-DJ-1 AC, mouse monoclonal Santa Cruz Biotechnology Cat# sc-55572 AC 
Anti DJ-1 (Oxidized At C106) BioRad Cat# HCA024 
Anti-Biotin-Peroxidase, mouse monoclonal Sigma Aldrich Cat# A0185 
Anti-Dimedone, rabbit polyclonal From Dr. Carroll’s lab (The 
Scripps Research Institute) 
(Seo and Carroll, 2009) 
Mouse IgGκ BP-HRP Santa Cruz Biotechnology Cat# sc-516102 
Mouse anti-rabbit IgG-HRP Santa Cruz Biotechnology Cat# sc-2357 
Swine anti-rabbit IgG-HRP, polyclonal Dako, Denmark Cat# P0399 
Donkey anti-mouse IgG-HRP, polyclonal  Abcam, Cambridge, UK Cat# ab6820 
Streptavidin Protein, DyLight 488 Thermo Fisher Scientific Cat# 21832 
Cy®5-Streptavidin Sigma Aldrich Cat# GEPA45001 
EGF Pathway Phospho Antibody Array Full Moon Biosystems Cat# PEG214 
Bacterial and Virus Strains   
OP50-1 Caenorhabditis Genetic Center N/A 
HB101 Caenorhabditis Genetic Center N/A 
E.coli MG1655 (pTrc99a) 
 
From the laboratory of 
Gonzales-Zorn, Spain 
N/A 
E.coli MG1655 (pSB74) From the laboratory of 
Gonzales-Zorn, Spain 
N/A 
E. coli BL21 DE3 Rosetta Novagen Cat# 70954-3 
   
Biological Samples   
Kidneys from C57BL/6 WT and CSE-/- mice From Professor Maik Gollasch 
(Charité Medical Faculty) 
(Markó et al., 2016) 
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D. melanogaster: y1w1118 From Professor Ody Sibon 
(University of Groningen) 
(Snijder et al., 2015) 
D. melanogaster: Eip55E From Professor Ody Sibon 
(University of Groningen) 
(Snijder et al., 2015) 
Chemicals, Peptides and Recombinant Proteins  
Chelex-100 Sigma Aldrich Cat# C7901 
Sodium Sulfide Sigma Aldrich Cat# 407410 
GYY4137 (Alexander et al., 2015) N/A 
AP39 (Szczesny et al., 2014) N/A 
D-cystine Sigma Aldrich Cat# 30095 
DL-propargylglycine Sigma Aldrich Cat# P7888 
O-(Carboxymethyl)hydroxylamine 
hemihydrochloride 
Sigma Aldrich Cat# C13408 
Hydrogen Peroxide Sigma Aldrich Cat# 216763 
Monensin sodium salt Sigma Aldrich Cat# M5273-1G 
Erastin Sigma Aldrich Cat# E7781 
S-sulfocysteine (SSC) Sigma Aldrich Cat# C2196 
Cystine Sigma Aldrich Cat# 30200 
Imidazole Carl Roth Gmbh Cat# 3899.4 
Isopropyl β-D-1-thiogalactopyranoside Inalco Pharmaceuticals Cat# 1758-1400 
Dithiothreitol (DTT) GE Healthcare Cat# 17-1318-02 
4-Chloro-7-nitrobenzofurazan (NBF-Cl) Sigma Aldrich Cat# 163260 
Dimedone Sigma Aldrich Cat# D153303 
DCP-Bio1 Kerafast Cat# EE0028 
DAz-2 Cayman Chemicals Cat# 13382 
BioDiaAlk (Akter et al., 2018)  N/A 
DiaAlk (Akter et al., 2018)  N/A 
Cyanine5 alkyne Lumiprobe Cat# FP-OO5590 
Copper(II)-TBTA Lumiprobe Cat# 21050 
L-Ascorbic acid Sigma Aldrich Cat# 795437 
Nmc-penicillamine (Artaud and Galardon, 2014) N/A 
EGF human recombinant PromoKine Cat# 60170 
VEGF-165, human, recombinant PromoCell Cat# C-64422 
Insulin human Sigma Aldrich Cat# I0908 
Paraformaldehyde Sigma Aldrich Cat# P6148 
Sodium thiosulfate PROLABO Cat# 27 910.291 
Paraquat hydrochloride hydrate Sigma Aldrich Cat# 36541 
Sodium (meta)arsenite Sigma Aldrich Cat# S7400 
2-deoxy-D-glucose (DOG) Sigma Aldrich Cat# D8375 
Thiazolyl Blue Tetrazolium Bromide (MTT) Sigma Aldrich Cat# M5655 
Protease Inhibitor Sigma Aldrich Cat# P8340 
His-Pur Ni-NTA Superflow Agarose ThermoScientific Cat# 25216 
Streptavidin Magnetic Beads Sigma Aldrich Cat# 11 641 778 001 
NeutrAvidin Agarose Resin ThermoScientific Cat# 29201 
High Capacity NeutrAvidin Agarose Resin ThermoScientific Cat# 29202 
Trypsin from porcine pancreas Sigma Aldrich Cat# T6567 
Chymotrypsin Sequencing Grade Sigma Aldrich Cat# 000000011418467001 
Human Serum Albumin Sigma Aldrich Cat# A1887 
GAPDH Sigma Aldrich Cat# G2267 
Rhodanese from bovine liver Sigma Aldrich Cat# R1756 
MnSOD Creative BioMart Cat# SOD2-1039H 
Cytochrome c Sigma Aldrich Cat# 30398 
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Xanthine Sigma Aldrich Cat# X0626 
Xanthine Oxidase Sigma Aldrich Cat# X1875 
Thioredoxin Reductase (TrxR) from rat liver Sigma Aldrich Cat# T9698 
TRP14 (From human fibroblast cDNA) For this paper N/A 
hsTrx C32S For this paper N/A 
hsTrx C35S For this paper N/A 
hsTrx1 For this paper N/A 
NADPH Sigma Aldrich Cat# N5130 
DAPI Euromedex Cat# 1050-A 
MeRho-Az From Michael D. Pluth’s lab 
(Dept. of Chemistry and 
Biochemistry, Eugene, OR) 
N/A 
Propidium Iodide Sigma Aldrich Cat# P4864 
Histowax® Histolab Product AB, Sweden Cat# 00405 
Normal swine serum  Dako, Denmark Cat# X0901 
Normal donkey serum Abcam, Cambridge, UK Cat# X0903 
Diaminobenzidine tetrahydrochloride (DAB) Dako North America, Inc. 
Carpinteria, CA, USA 
Cat# K3468 
DPX medium Sigma-Aldrich Cat# 06522 
Experimental Models: Cell Lines   
Human: HeLa ECACC Cat# 93021013 
Human: HUVEC PromoCell Cat# C-12203 
Human: SH-SY5Y ECACC Cat# 94030304 
Human: Fibroblasts Coriell Institute  AG08790 and AG14245 
Mouse: MEF WT From Prof. Snyder’s lab (Johns 
Hopkins University School of 
Medicine) 
(Sbodio et al., 2016) 
Mouse: MEF CSE-/- From Prof. Snyder’s lab (Johns 
Hopkins University School of 
Medicine) 
(Sbodio et al., 2016) 
Mouse: Striatal progenitor cells STHdhQ7/Q7 M. MacDonald (Massachusetts 
General Hospital, Boston, MA) 
N/A 
Mouse: Striatal progenitor cells STHdhQ111/Q111 M. MacDonald (Massachusetts 
General Hospital, Boston, MA) 
N/A 
Experimental Models: C.elegans mutants  
Wild-type Bristol N2 Caenorhabditis Genetic Center N/A 
cth-1(ok3319)V Caenorhabditis Genetic Center VC2569 
mpst-3(tm4387)V MITANI Lab, National Bio-
Resource Project of the MEXT, 
Japan 
FX04387 
eat-2(tm5786)II MITANI Lab, National Bio-
Resource Project of the MEXT, 
Japan 
FX19451 
eat-2(tm5786)II;cth-1(ok3319)V This paper N/A 
eat-2(tm5786)II;mpst-3(tm4387)V This paper N/A 
Experimental Models: Strains/Organisms  
S. cerevisiae: BY4742 (WT) Euroscarf N/A 
S. cerevisiae: Δcys4 Euroscarf ACCNO Y16696 
S. cerevisiae: Δcys3 Euroscarf ACCNO Y16865 
S. cerevisiae: Δtum1 Euroscarf ACCNO Y12507 
Male Wistar Rat 
 
 
Institute for Biological Research 




Male C57BL/6J mice NIA Aging Colony Resource at 
Charles River Laboratories 
(CRL) 
N/A 
C57BL/6 mice Department of Pharmacology 
and Molecular Sciences, Johns 
Hopkins University School of 
Medicine, Baltimore, MD 
N/A 
Oligonucleotides   
5’-GAAGGAGATATACCATGGTGAAGC-3’ 
(fwd) 
Sigma Aldrich hsTrx in pET28a 
5’-CGGATCTCAGTGGTGGTG-3’ (rev) Sigma Aldrich hsTrx in pET28a 
5’-CACGTGGTCTGGGCCTTG-3’ (fwd) Sigma Aldrich hsTrx C32S mutagenesis 
5’-CAAGGCCCAGACCACGTG-3’ (rev) Sigma Aldrich hsTrx C32S mutagenesis 
5’-GTGTGGGCCTTCCAAAATGATCAAG-3’ 
(fwd) 
Sigma Aldrich hsTrx C35S mutagenesis 
5’-CTTGATCATTTTGGAAGGCCCACAC-3’ 
(rev) 








Sigma Aldrich hsTRP14 in pQE-80L 
Recombinant DNA   
Plasmid: pET-28a(+) Novagen Cat# 69864-3 
Plasmid: pQE-80L Qiagen N/A 
Software and Algorithms   
ImageJ NIH https://imagej.nih.gov/ij/dow
nload.html 
GraphPad Prism 5.0 GraphPad Software https://www.graphpad.com 
PEAKS Studio Bioinformatics Solutions Inc. http://www.bioinfor.com/ 
OriginPro 8 OriginLab https://www.originlab.com/ 
RTCA Software Version 2.0 ACEA Biosciences, Inc. https://www.aceabio.com/pr
oducts/rtca-dp/ 
CFLow Plus Version 1.0.202.1 BD Biosciences http://www.bdbiosciences.co
m 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to, and will be fulfilled by the Lead 
Contact, Milos Filipovic (milos.filipovic@ibgc.cnrs.fr) 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Cell Lines 
HeLa cells and Neuroblastoma cells (SH-SY5Y) were both obtained from ECACC. HeLa cells were cultured in 
Dulbecco’s modified Eagle’s media (DMEM, high glucose) supplemented with 2 mM L-glutamine, 1% penicillin-
streptomycin and 10% fetal bovine serum at 37 °C and 5% CO2. SH-SY5Y (ECACC) cells were cultured in Ham's 
F12 : DMEM (1 : 1) media, supplemented with  2 mM glutamine, 1% penicillin-streptomycin and 10% fetal bovine 
serum at 37 °C and 5% CO2. C-pooled human umbilical vein endothelial cells (HUVEC) were obtained from 
PromoCell, Germany and cultured in Endothelial Cell Growth Medium I Kit (PromoCell, Germany) at 37 °C and 5% 
CO2. Mouse Embryonic Fibroblasts (MEF) were generated from CSE+/+ and CSE−/− mice and immortalized using 
SV40T antigen (Sbodio et al., 2016). MEF cells were cultured in DMEM (high glucose), supplemented with 2 mM 
L-glutamine, 1% penicillin-streptomycin and 10% fetal bovine serum at 37 °C and 5% CO2. The striatal progenitor 
cell line STHdhQ7/Q7, expressing wild-type huntingtin, and STHdhQ111/Q111, expressing mutant huntingtin, harboring 
111 glutamine repeats (referred to as Q7 and Q111 cells, respectively), were from M. MacDonald (Massachusetts 
General Hospital, Boston, MA). The cells were maintained in DMEM (low glucose, no pyruvate) supplemented with 
 40 
2 mM L-glutamine, 1% penicillin-streptomycin and 10% fetal bovine serum at 33 °C and 5% CO2. Human Fibroblasts 
cell lines AG08790 (31 years old) and AG14245 (48 years old - a culture initiated from a biopsy taken 17 years earlier 
from this same donor is AG08790) were obtained from Coriell Institute for Medical Research. Fibroblasts were 
cultured in DMEM (high glucose) supplemented with 2 mM L-glutamine and 10% fetal bovine serum at 37 °C and 




The following strains were used in this study: Wild-type Bristol N2, cth-1(ok3319)V, mpst-3(tm4387)V, eat-
2(tm5786)II, eat-2(tm5786)II;cth-1(ok3319)V, eat-2(tm5786)II;mpst-3(tm4387)V. The original isolate VC2569 cth-
1(ok3319)V was provided by the Caenorhabditis Genetic Center whereas the original isolates FX04387 mpst-
3(tm4387)V and FX19451 eat-2(tm5786)II were provided by the MITANI Lab through the National Bio-Resource 
Project of the MEXT, Japan. All mutant strains were outcrossed at least 4 times before use. Double-mutant strains 
were constructed by using standard techniques (Brenner, 1974; Sulston and Hodgkin, 1988) and the presence of both 
mutations were checked by PCR. Worms were grown at 20 °C on standard nematode growth medium (NGM) plates, 
unless otherwise indicated, using standard C. elegans techniques (Stiernagle, 2006) with sufficient food (E. coli OP50-
1) for at least two generations prior to use. 
 
S. cerevisiae 
Yeast cells were grown in liquid YPD media (1% yeast extract, 1% bactopeptone, and 2% glucose).  
 
Wistar rats 
Male Wistar rats used in the experiment were bred and housed at the Institute for Biological Research “Siniša 
Stanković”, Belgrade, Serbia, under constant laboratory conditions (22±2˚C, 12–12 hr light-dark cycle). Food and 
water were available ad libitum. The animals were decapitated at the ages of 1, 3, 6, 12 and 24 month(s). All animal 
procedures were in compliance with the EEC Directive (86/609/EEC) on the protection of animals used for 
experimental and other scientific purposes and were approved by the Ethical Committee for the Use of Laboratory 
Animals of the Institute for Biological Research "Siniša Stanković", University of Belgrade.  
 
Male C57BL/6J mice 
All experiments were performed with the approval of the Harvard Medical Area Institutional Animal Care and Use 
Committee (IACUC). Male C57BL/6J mice were obtained from the NIA Aging Colony Resource at Charles River 
Laboratories (CRL) at 6 months (young) and 19 months (old) of age. Mice were allowed to acclimatize to the facility 
for one month to ensure weight stabilization after shipment, so at sacrifice were 7mo old (young) and 20 months (old). 
Initiation of caloric restriction (CR) was performed as previously described (Turturro, A., et al., 1999) (starting at 14 
weeks of age, CR is initiated in a step-down fashion, where it its increased to 25% restriction at 15 weeks, and the full 
40% restriction imitated at 16 weeks where it is maintained throughout the life of the animal. Ad libitum (AL) animals 
were fed NIH-31 diet, while CR animals are fed NIH-31 fortified diet (Turturro, A., et al., 1999). Other details about 
the husbandry conditions at CRL can be found here: https://www.nia.nih.gov/research/dab/aged-rodent-colonies-
handbook/barrier-environmental-information.  
Mice were single housed for the duration of their life in standard mouse cages. Upon arrival at Harvard, mice 
were housed in the barrier facility at HSPH in microisolator cages with corncob bedding, a nestlet and one shepherd 
shack. Mice receive free access to water, and either AL NIH-31, or fortified NIH-31 (1 pellet per day for the CR mice). 
CR mice were fed daily between the hours of 7:00-8:00am by feeding the ration of food onto the floor of the cage. 
Any remaining food was removed the next day prior to giving the new food ration. Mice were housed in a room on a 
12/12 hr light/dark cycle (7am-7pm) with temperature between 20–23 °C with 30%–70% relative humidity. Cages 
were changed weekly using full sterile technique and performed in Class II laminar flow change stations with spot 
changes as required.  
 





All chemicals were purchased from Sigma Aldrich, unless otherwise mentioned. All buffers were prepared with 
nanopure water and treated with Chelex-100 resins to remove traces of metal ions. Na2S solutions were prepared and 
handled as recommended (Wedmann et al., 2014). Nmc-penicillamine was synthesized, as previously described 
(Artaud and Galardon, 2014). Morpholin-4-ium 4 methoxyphenyl(morpholino) phosphinodithioate (GYY4137) and 
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(10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl)triphenylphosphonium bromide (AP39) were 
synthesized in house according to (Alexander et al., 2015; Le Trionnaire et al., 2014). 
 
Preparation of Specific oxPTM of Proteins 
Preparation of HSA-SH, HSA-SOH and HSA-SSH 
Different oxPTM of HSA were prepared and their concentrations quantified as previously reported (Cuevasanta et al., 
2015).  
Preparation of GAPDH persulfide 
GAPDH persulfide was prepared as previously described for HSA derivatives (Cuevasanta et al., 2015). 
Preparation of TST and TST persulfide 
Bovine TST (Sigma Aldrich) (already largely present as a persulfide) was used to prepare the fully persulfidated 
enzyme, by incubating with a 10-fold excess of sodium thiosulfate in 10 mM Tris buffer (pH 8) at 37 °C for 30 min 
and then cleaning with mini biospin column from Bio-Rad. The reduced enzyme was prepared by incubating with a 
10-fold excess of DTT at 37 °C for 30 min and then cleaned on a mini biospin column. 
 
Dimedone Switch Method to Purified Proteins  
Proteins were incubated with 5 or 10 mM NBF-Cl, in PBS containing 2% SDS for 30 min at 37 °C, precipitated by 
methanol/chloroform precipitation (CHCl3/H2O/MeOH (1/4/4, v/v/v) 2 times and subsequently washed with MeOH 
2-3 times). Pellets were resuspended in 50 mM PBS (40mM Na2HPO4, 10 mM NaH2PO4 and 130 mM NaCl, pH 7.4) 
containing 2% SDS, incubated with either 50 M dimedone or DCP-Bio1 for 1 hr at 37 °C, precipitated with 
CHCl3/H2O/MeOH (1/4/4, v/v/v) twice, and re-suspended in Laemmli buffer for SDS-PAGE. For some experiments, 
the DCP-Bio1-labeled samples were redissolved in 50 mM PBS only, incubated with neutravidin beads (Thermo 
Fischer Scientific) for 2 hr at room temperature with continuous mixing. Beads were then washed with 10 volumes of 
PBS (containing 0.01% Tween-20) and bound proteins were eluted by boiling the beads in a minimum volume of 
Laemmli buffer for SDS-PAGE for 5 min and gels were recorded on a Typhoon Fla 9500 at 473 nm and 635 nm. 
 
ESI-TOF MS of the dimedone switch reaction with LMW persulfides 
Mass spectrometry was performed on maXis 5G, Bruker Daltonic (Bremen, Germany), an ESI-TOF MS capable of 
resolution of at least 40,000 FWHM. Detection was in positive-ion mode. 100 μM nmc-penicillamine persulfide was 
mixed with 100 μM NBF-Cl in ammonium bicarbonate buffer, (pH 7.4, 23 °C) and the reaction monitored for 15 min. 
500 μM dimedone was then added and the reaction monitored for an additional 15 min.  
 
MS of Protein Persulfide Models Labeled with DCP-Bio1 
Protein persulfides switch labeled with DCP-Bio1 as previously described and resolved by SDS-PAGE, and protein 
bands excised and digested with either trypsin or chymotrypsin following previously described protocol (Crouzet et 
al., 2017). Trypsin digested peptides were analyzed by LC-MS/MS on a Thermo Scientific Q Exactive Orbitrap mass 
spectrometer in conjunction with a Proxeon Easy-nLC II HPLC (Thermo Fisher Scientific) and Proxeon nanospray 
source at Bordeaux Proteomic Platform. The digested peptides were loaded a 100 micron x 25 mm Magic C18 100Å 
5U reverse phase trap where they were desalted online before being separated with a 75 micron x 150 mm Magic C18 
200Å 3U reverse phase column. Peptides were eluted using a 120 min gradient with a flow rate of 300 nL/min. An 
MS survey scan was obtained for the m/z range of 350-1600; MS/MS spectra were acquired using a top 12 method, 
where the top 12 ions in the MS spectra were subjected to High Energy Collisional Dissociation (HCD). An isolation 
mass window of 2 m/z was used for the precursor ion selection, and normalized collision energy of 27% was used for 
fragmentation. Five second duration was used for the dynamic exclusion. Peptide identification was performed using 
PEAKS Studio (BSI, Canada) (Zhang et al., 2012). The search settings were: precursor ∆m tolerance = 10 ppm, 
fragment ∆m tolerance = 0.2 Da, missed cleavages = 2, modifications of lysine: NBF (163.0012), modifications of 
cysteine: NBF (163.0012), DCP-Bio1 (394.1557), or hydrolyzed DCP-Bio1 (168.0786). 
 
Proteomic Analysis of Persulfidated Proteins in Red Blood Cell Lysates 
9 mL of peripheral whole blood from participants of this study, who provided informed consent in accordance with 
the Declaration of Helsinki, was collected in citrate and processed immediately following previously described 
protocol (Pasini et al., 2006) with modification that the lysis buffer contained 5 mM NBF-Cl. After 30 min of 
incubation with lysis buffer at 4 °C, additional NBF-Cl was added (to final concentration of 15 mM NBF-Cl) with 
SDS (to final concentration of 2%) and incubated for 30 min. Methanol/chloroform precipitation was performed and 
the protein pellet obtained was redissolved in 50 mM PBS supplemented with 0.1% SDS.  Endogenously biotinylated 
proteins were precleared by incubating with Pierce™ NeutrAvidin™ Agarose (ThermoFisher) at room temperature 
for 2 hr with agitation. The resins were subsequently removed on a Pierce™ Disposable Column (ThermoFisher) and 
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the solution obtained was precipitated by methanol/chloroform. The resulting protein pellet was redissolved in 50 mM 
PBS supplemented with 2% SDS and was incubated with 50 µM DCP-Bio1 at 37 °C for 1.5 hr. Solution was 
precipitated with methanol/chloroform and redissolved in 50 mM PBS supplemented with 0.1% SDS. The protein 
solution was incubated with Pierce™ High Capacity NeutrAvidin™ Agarose (ThermoFisher) at 4 °C overnight with 
agitation. Samples were then brought to room temperature and loaded on a column. The resins were washed with 8 
column volumes of 50 mM PBS supplemented with 0.001% Tween, 2 column volumes of 50 mM PBS and finally 
with 1 column volume of H2O. After washing, the resins were collected from the column and incubated with 2.25 M 
ammonium hydroxide at room temperature, overnight with agitation. The sample was then neutralized with formic 
acid and protein concentration was determined. 1 equivalent of enzyme digestion buffer was added (for trypsin 
digestion: 100 mM ammonium bicarbonate buffer (Sigma); for chymotrypsin digestion: 100 mM Tris and 10 mM 
CaCl2, pH 7.8). Digestion was performed at an enzyme-to-substrate ratio of 1:50 (wt:wt) and incubated at 37 °C 
overnight with agitation. Enzyme was added again to solution at an enzyme-to-substrate ratio of 1:20 (wt:wt) and re-
incubated at 37 °C for 5 hr with agitation. The resulting peptide sample was then quenched by bringing to pH 3, with 
conc. HCl, and analyzed at Bordeaux Proteomic Platform. Trypsin digested peptides were analyzed by LC-MS/MS 
on a Thermo Scientific Q Exactive Orbitrap mass spectrometer in conjunction with a Proxeon Easy-nLC II HPLC 
(Thermo Fisher Scientific) and Proxeon nanospray source. Samples were separated on 300-µm ID x 5-mm C18 
PepMapTM precolumn and 75 µm ID x 25 cm nanoViper C18, 2 µm, 100 Å – Acclaim® PepMap RSLC column using 
4-40% gradient of B (A: H2O/MeCN/HCOOH, 95/05/0.1, B: H2O/MeCN/HCOOH, 20/80/0.1). Peptides were eluted 
using a 120 min gradient with a flow rate of 300 nL/min. An MS survey scan was obtained for the m/z range of 350-
1600; MS/MS spectra were acquired using a top 12 method, where the top 12 ions in the MS spectra were subjected 
to High Energy Collisional Dissociation (HCD). An isolation mass window of 2 m/z was used for the precursor ion 
selection, and normalized collision energy of 27% was used for fragmentation. Five second duration was used for the 
dynamic exclusion. Peptide identification was performed using PEAKS Studio (BSI, Canada). The search settings 
were: precursor ∆m tolerance = 10 ppm, fragment ∆m tolerance = 0.2 Da, missed cleavages = 2, -10logP>50, 
modifications of lysine: NBF (163.0012), modifications of cysteine: NBF (163.0012), DCP-Bio1 (394.1557), or 
hydrolyzed DCP-Bio1 (168.0786). 
 
In Gel Detection of Persulfidation (Dimedone Switch Method) 
Preparation of DAz-2:Cy-5 Click Mix 
1 mM DAz-2 (Cayman Chemical), 1 mM Cyanine5 alkyne (Lumiprobe), 2 mM copper(II)-TBTA complex 
(Lumiprobe) and 4 mM ascorbic acid made in situ, was added in 15 mM PBS buffer with 30% acetonitrile. The 
solution was mixed at room temperature overnight and quenched with 20 mM ethylenediaminetetraacetic acid 
(EDTA). 
 
Persulfide Detection in Cell Lysates 
Two 100 mm dishes of 80-90% confluent HeLa cells were lysed in cold HEN lysis buffer (50 mM Hepes, 1 mM 
EDTA, 0.1 mM Neocuproine, 1% IGEPAL and 2% SDS, adjusted to pH 7.4) supplemented with 1% protease inhibitor 
(Sigma) in the control dish and with an additional 5 mM 4-chloro-7-nitrobenzofurazan (NBF-Cl) in the second dish. 
Both dishes were gently scrapped, lysates were collected, homogenized with a syringe and needle and immediately 
placed for incubation at 37 °C for 30 min, protected from light. A methanol/chloroform precipitation was performed 
and protein pellets obtained were washed with cold methanol, dried, protected from light and redissolved in 50 mM 
Hepes (Euromedex, adjusted pH 7.4) supplemented with SDS (final conc. 2%). When fully dissolved, protein 
concentration was determined using DC Assay (BioRad) and adjusted to 2-3 mg/ml. Each protein sample was 
separated into two tubes; to one of the control sample tubes and one NBF-Cl lysed sample tubes, 25 μM of DAz-2:Cy-
5 click mix prepared without DAz-2, as described above was added. Additionally, in the remaining control and NBF-
Cl lysed sample tubes, 25 μM of DAz-2:Cy-5 click mix prepared as described above was added. All four tubes were 
placed for incubation at 37 °C for 30 min, protected from light. Following incubation, methanol/chloroform 
precipitation was performed as described above and the protein concentration was determined and adjusted to 2-2.5 
mg/ml. 1 equivalent of Laemmli (4X) buffer (BioRad) supplemented with 10% β-mercaptoethanol was added to 3 
equivalents of sample and boiled at 95°C for 5 min protected from light. Samples were resolved by SDS-PAGE and 
gels were fixed in fixation buffer for 30 min, protected from light. The gel was recorded, at 635 nm for the Cy5 signal 
and 473 nm for NBF-Cl signal, on the Typhoon FLA 9500 (GE Healthcare). 
The H2S donor treatments were performed with 200 μM Na2S for 45 min, 200 μM GYY4137 for 2 hr, 200 
nM AP39 for 2 hr and 2 mM D-Cysteine for 1 hr, all at 37 °C and 5% CO2. Erastin treatments were preformed with 1 
μM and 10 μM Erastin for 18.5 hr. Monensin treatments were performed by treating cells with 1 μM for 18 hr, both 
at 37 °C and 5% CO2.  Cells were lysed and processed as previously described.   
 
Persulfide Detection in Escherichia coli Lysates 
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The laboratory strain E. coli MG1655 was transformed with the pSB74 plasmid that contains the phsABC operon of 
S. Enterica serovar Typhimurium for H2S production. As a negative control, E. coli was transformed with an empty 
vector (pTrc99a). Both strains were streaked on TSA plates supplemented with ampicillin 50 mg/ml, and incubated 
overnight at 37 °C. The next day, one colony of each strain was inoculated into TSB medium supplemented with 50 
mg/ml of ampicillin and grown at 37 °C with agitation (100 rpm), as a starter inoculum. 10 μl of each of these 
overnight-grown cultures were transferred into 10 ml of fresh TSB medium supplemented with the appropriate 
antibiotic. Both strains were treated with 20 mM sodium thiosulfate for 4 hr at 37 °C with agitation (120 rpm). After 
the incubation time, samples were harvested by centrifugation at 5000 rpm for 4 min, washed with ice-cold PBS and 
resuspended in HEN lysis buffer supplemented with 1% protease inhibitor and 25 mM NBF-Cl. Cells were disrupted 
on ice by sonication, 20 seconds at 190 MHz 2 times with a 2 min pause, and incubated at 37 °C for 1 hr, protected 
from light. Samples were then precipitated and dissolved as previously described and incubated with 50 μM DAz-
2:Cy5 preclick mix, for 1 hr at 37 °C protected from light. 
 
Persulfide Detection in Saccharomyces cerevisiae Lysates 
For persulfide detection 200 μL yeast cells of WT, Δcys3, Δcys4 and Δtum1 strains were mixed with 1 mL HEN lysis 
buffer supplemented with 1% protease inhibitor for yeast and 20 mM NBF-Cl. Mixture was added dropwise into liquid 
nitrogen and grinded using a mortar and pestle, together with glass beads, reaching a fine powder consistency. Samples 
were transferred in 2 ml tubes and centrifuged on 1500 x g for 15 min at 4 °C. Supernatants were collected and 
incubated at 37 °C for 1 hr, protected from light. After precipitation, protein pellets were processed as previously 
described with 50 μM DAz-2:Cy5 preclick mix for 45 min at 37 °C. 
 
Persulfide Detection in Caenorhabditis elegans Lysates 
Synchronous populations of embryos were obtained by lysing gravid hermaphrodites in alkaline bleach as described 
by Emmons et al. (1979). Once washed free of the alkaline bleach by centrifugation, the embryos were inoculated on 
standard NGM agar plates, ~4000 embryos/plate. At Day-1 adult stage worms of different strains (N2, cth-1, mpst-3, 
eat-2, eat-2;cth-1, eat-2;mpst-3) were collected from the NGM plates, 4 plates/strain, into 15 ml falcons using M9 
buffer and washed three times. Worm pellets were frozen in liquid nitrogen and 500 μl of glass beads was added in 
every tube. Samples were put in the bead beater (FastPrep-24, MP Biomedicals, California, USA) for 35 seconds at 
speed 6.5 m/s, followed by an additional cycle at the same speed for 20 seconds. HEN lysis buffer supplemented with 
1% protease inhibitor and 20mM NBF-Cl was added to each tube, and centrifuged for 15 min at 13000 rpm at 4°C. 
Supernatants were collected and incubated at 37 °C for 45 min. Protein pellets were processed and labeled with 25 
μM DAz-2:Cy5 preclick mix, as previously described. 
Synchronous populations of embryos were obtained as described above, and inoculated on standard NGM 
agar or NGM agar plates supplemented with 1 mM sodium thiosulfate seeded with E. coli OP50-1. The plates were 
then incubated at 20°C until worms reached Day-1 adult stage. Worms were collected from the plates and processed, 
as previously described.  
 
Persulfide Detection in Drosophila melanogaster Lysates 
As wild-type control, the y1w1118 Drosophila line was used. Eip55E (Drosophila CSE)-overexpressing lines were a 
kind gift from Professor Ody Sibon (University of Groningen). 3-4 whole flies were grinded in dounce homogenizer 
with 50 L of HEN lysis buffer supplemented with 1% protease inhibitor and 20 mM NBF-Cl on ice. Homogenates 
were centrifuged at 30 000 x g for 20 min and the supernatant was incubated for 30 min at 37 °C, protected from light. 
Next, persulfide labeling was performed as previously described. 
 
Persulfide Detection in Mouse Kidney Lysates 
CSE +/+ and CSE −/− C57BL/6 mice were generated and previously characterized (Markó et al., 2016). CSE+/− males 
and females were bred to obtain CSE+/+ and CSE−/− littermates. Mice were allowed free access to standard chow and 
water. The mice were kept in a 12:12-h light-dark cycle. The kidneys from these mice were kind gift from Professor 
Maik Gollasch (Charité Medical Faculty). 5-10 mg of kidney tissue was homogenized with 500 L of HEN lysis 
buffer supplemented with 1% protease inhibitor and 20 mM NBF-Cl on ice in dounce homogenizer. Homogenates 
were centrifuged at 30 000 x g for 20 min and the supernatant was incubated for 30 min at 37 °C, protected from light. 
Next, persulfide labeling was performed as previously described. 
 
Persulfide Detection in Rat Tissue Lysates  
Immediately after decapitation, the brain, heart and liver were quickly removed and snap frozen in liquid nitrogen. 
The organs were shredded and homogenized in HEN lysis buffer supplemented with 1% protease inhibitor and 20 
mM NBF-Cl using a dispersion system (Ultra-Turax T25, Janke & Kunkel, IKA-Labortechnik, Germany) at 8000 rpm 
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on ice. After 1 hr incubation at 37 °C protected from light, samples were precipitated and processed as previously 
described with 50 μM DAz-2:Cy5 click mix for 45 min at 37 °C. 
 
Persulfide Detection in Liver of Aging Mice following dietary restriction (AL and CR) 
On the day of the experiment, mice were brought to the procedure room (6.30 am) and placed in clean cages. Food 
for AL mice was transferred to the hopper, and CR mice were fed per usual at 7am with one pellet per mouse on the 
floor of the cage. They were allowed to eat for 2 hr and then starting at 9am, mice were anesthetized with isoflurane 
(2-5% in oxygen) and a cardiac puncture was performed to withdraw blood. Cervical dislocation was performed to 
ensure euthanasia and tissues were excised and snap frozen in liquid nitrogen. From the time of cervical dislocation 
to excision and snap freezing of the liver, this period did not exceed 30 seconds (mice were not fasted for this 
experiment). 20 mg of liver was cut into small pieces with a scalpel placed in 1 ml of HEN buffer supplemented with 
1% protease inhibitor and 20 mM NBF-Cl, which were then homogenized using a dispersion system on ice and 
processed as previously above.  
 
Persulfide Detection in Skeletal Muscle of Mice following a Glucose Tolerance Test 
A glucose tolerance test (GTT) was performed on 2- old and 12- month old mice which were fasted for 16 hr prior to 
being injected i.p. with D-glucose (2 g/kg body weight). Blood glucose level was recorded by tail vein bleeding 
immediately before and at indicated time points (15 min and 60 min) after injection using an Ascensia Contour blood 
glucose meter and test strips. At the indicated time points, the mice were euthanized by cervical decapitation and the 
skeletal muscle was isolated and snap frozen in liquid nitrogen. 20 mg of frozen muscle was cut in to small pieces 
with a scalpel and placed in 2 ml of HEN buffer supplemented with 1% protease inhibitor and 20 mM NBF-Cl. The 
suspension was then homogenized using a dispersion system on ice and processed for persulfidation labelleing as 
described above. 
 
Persulfide Detection in Human Erythrocyte Lysates 
Erythrocyte lysates were prepared in two ways, to obtain membranes and cytosol. Packed erythrocytes were lysed 
with 5 volumes of 10 mM phosphate buffer containing 5 mM NBF-Cl for 30 min at 4 °C with frequent vortexing. 
After 20 min centrifugation (30,000 x g) supernatant was separated from cell membrane pellet. SDS (for a final conc. 
of 2%) and 10 mM NBF-Cl (final concentrations) were added to the supernatant and incubated for an additional 60 
min at 4 °C. Membrane pellets were washed 3 times with PBS containing 5 mM NBF-Cl, and then resuspended in 
PBS containing 5 mM NBF-Cl and SDS (final conc. 2%) and incubated for 30 min at 37 °C. Both membrane and 
cytosol proteins were precipitated as previously described, and persulfides labeled with 50 μM DAz-2:Cy5 click mix 
for 45 min at 37 °C. 
 
Persulfidation Detection by Confocal Microscopy and Epifluorescence Deconvolution Microscopy 
CSE+/+ and CSE-/- MEF cells were grown in μ-dishes (35 mm, Ref. 81158) obtained from Ibidi® (Martinsried, 
Germany) following manufacturer's instructions. The treatments with 2 mM D-cysteine and 200 μM Na2S (H2S) were 
performed over 1 hr at 37 °C. After treatments, the cells were washed twice with warm sterile PBS, and incubated 
with 1 mM NBF-Cl in PBS for 30 min at 37 °C. Fixation was carried out by incubation with ice-cold methanol at -20 
°C for 20 min and subsequent permeabilization with ice-cold acetone at -20 °C for 5 min. The dishes were washed 
with PBS and incubated with 1 mM NBF-Cl in PBS for 1 hr at 37 °C.  Cells were washed with PBS overnight, and 
incubated with 10 μM DAz-2:Cy-5 click mix in PBS for 1 hr at 37 °C. For the negative control cells were incubated 
with 10 μM DAz-2:Cy-5 click mix prepared without DAz-2. After overnight washing with PBS, cells were washed 
with methanol 3 x 10 min, followed by an additional washing with PBS. DAPI staining was performed according to 
the manufacturer's recommendation. Images were obtained using a Confocal Leica TCS SP5 microscope equipped 
with an Argon laser (458, 476, 488, 514 nm), a diode laser (405 nm) and Helium-Neon laser (633 nm). A x40 oil 
objective lens was used. For examination of co-localization of immunofluorescence, single optical sections at the same 
focus plane were taken separately and the three corresponding channels were merged into a 8-bit RGB tiff-file using 
ImageJ. Z-stack images were taken on Olympus IX81 inverted fluorescence microscope using x 100 oil objective lens, 
used for image deconvolution.   
 
Antibody Array-like Approach for Detection of Persufidation 
Each antibody was added into the appropriate wells of a 96 well plate with 3D-NHS Surface (PolyAn, Berlin) at a 
final volume of 50 μl in PBS buffer (150 mM Na2HPO4 / NaHPO4 and 50 mM NaCl, pH 8.5). Additionally, in the 
negative control wells 50 μl of 5% BSA in TBST (137 mM NaCl, 20 mM Trizma base, 0.1% Tween) and 0.002% 
NaN3 was added.  The plate was covered and incubated at 4 °C overnight with agitation. The solutions were discarded 
and the wells were washed 5 times with 15 mM PBS Tween using a multi-channel and inverting the clean plate against 
paper towels for complete removal of liquid. All wells were then blocked with 50 mM ethanolamine in 100 mM Tris 
 45 
at pH 9 for 2 hr at room temperature with agitation. The blocking solution was discarded and wells were re-blocked 
with 5% BSA in TBS Tween for a further 1 hr at room temperature with agitation. Wells were washed again as 
described above. Following complete removal of liquid, 100 μl of treated samples were added to appropriate wells 
and incubated at 4 °C, overnight with agitation. After washing, the plate was recorded on Typhoon FL9500 at 473 nm 
and 635 nm. 
For experiments where CSE+/+, CSE−/− and CSE+/+ treated with D-cysteine MEF cells, lysates were obtained 
and labeled for persulfides, as previously explained. The following antibodies were used: 1. β-actin (0.04 mg/ml, sc-
47778, Santa Cruz Biotechnology); 2. β-tubulin (0.04 mg/ml, T0198, Sigma Aldrich); 3. GAPDH (0.04 mg/ml, G8795, 
Sigma Aldrich); 4. HSP70 (0.04 mg/ml, ab5439, Abcam); 5. KEAP1 P586 (0.0062 mg/ml, 4678, Cell Signalling); 6. 
eNOS (0.0025 mg/ml, 32027, Cell Signalling); 7. Parkin (0.04 mg/ml, sc-136989, Santa Cruz Biotechnology); 8. 
SOD-2 (0.04 mg/ml, sc-137254, Santa Cruz Biotechnology); 9. Anti-TST (0.04 mg/ml, GTX114858, GeneTex); 10. 
Anti-SQR (0.04 mg/ml, HPA017079, Sigma Aldrich). 
For experiments with lysates of HeLa cells treated in a time-dependent manner with EGF and labeled for 
persulfides as previously described. The following antibodies were used: PTEN (1:1000, sc-7974, Santa Cruz 
Biotechnology,); 2. PTP1B (1:1000, sc-133259, Santa Cruz Biotechnology); 3. SH-PTP2 (0.04 mg/ml, sc-7384, Santa 
Cruz Biotechnology); 4. EGFR (0.04 mg/ml, sc-03-G, Santa Cruz Biotechnology). 
 
MnSOD Persulfidation and Activity Experiments 
Human recombinant MnSOD was purchased from Creative BioMart. SOD activity was measured using cytochrome 
c assay, as described previously. Peroxynitrite was prepared following well established protocol (Filipovic et al., 2012) 
and tyrosine nitration assessed using characteristic spectral properties: an increase in the absorbance at 430 nm was 
attributed to nitrotyrosine formation due to the characteristic shift (from 430 to 357 nm) observed with decreasing pH 
(Filipovic et al., 2012). 
 
Detection of Protein Sulfenylation 
Following respective treatments, cells were lysed in cold HEN lysis buffer supplemented with 1% protease inhibitor 
and 100 μM DCP-Bio1. Cells were gently scrapped, lysate was collected, homogenized with a syringe and needle and 
immediately placed for incubation at 37 °C for 1 hr. A methanol/chloroform precipitation was performed and protein 
pellet obtained was redissolved in 50 mM Hepes with SDS (final conc. 2%). Protein pellets were prepared for SDS-
PAGE, as previously explained. After resolving samples on gel, protein transfer was performed, followed by blocking 
in 5% dry-milk in PBS Tween and incubated with Streptavidin Protein DyLight 488 in 50 mM PBS (1:10000, 21832, 
ThermoFisher) for 1 hr protected from light. Nitrocellulose membrane was recorded at 473 nm, using a Typhoon FLA 
9500 (GE Healthcare). 
 
Detection of Protein Sulfinylation 
Following respective treatments, cells were lysed in cold HEN lysis buffer supplemented with 1% protease inhibitor 
and 5 mM NBF-Cl or 20 mM NEM. Cells were gently scrapped, lysate was collected, homogenized with a syringe 
and needle and immediately placed for incubation at 37 °C for 30 min or 1 hr respectively. A methanol/chloroform 
precipitation was performed and protein pellet obtained was redissolved in 50 mM Hepes with 2% SDS. Protein 
concentration was determined and adjusted to 2.5 mg/ml. Samples were treated with 1 mM BioDiaAlk at room 
temperature for 1 hr, protected from light. Reaction was quenched by the addition of 1 mM DTT incubated overnight 
at 4 °C or preformed a methanol/chloroform precipitation. Sample were then mixed with 4X Laemmli (1:4) and 
incubated for 20 min at 55 °C. After resolving samples on gel, protein transfer was performed, followed by blocking 
in 5% dry-milk in PBS Tween and incubated with Streptavidin Cy5 (1:4000, 21832, ThermoFisher) for 1 hr protected 
from light. Nitrocellulose membrane was recorded at 635 nm, using a Typhoon FLA 9500 (GE Healthcare).  
 
Receptor Tyrosine Kinase Activation of Cells 
Activation Conditions 
EGF (PromoKine) treatments in HeLa and MEF cells, and insulin treatments in SH-SY5Y cells, were performed with 
cells cultured in 100 mm cell culture dishes at a 80-90% confluency. VEGF (PromoCell) treatments were performed 
with HUVECs cultured in T25 flasks (Greiner) at a 70-80% confluency. For pretreatments, media was replaced with 
complete media supplemented with 100 μM GYY4137 or inhibitor mix (PG and AOAA, 1 mM of each), incubated at 
37 °C and 5% CO2 for 30 min and then washed with warm sterile PBS. Subsequently, media was replaced with 
complete media (as described above) for control and media supplemented with respective treatments (100 or 200 
ng/ml EGF; 100 nM or 200 nM insulin; 40 ng/ml VEGF). Following treatments, cells were washed with cold PBS 
twice and lysed for persulfide or sulfenic acid labeling, as previously explained.  
 
Real-time activity of EGFR in HeLa cells 
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Cells were seeded at 1x104 cell/well in an equilibrated E-Plate VIEW 16 PET and grown overnight at at 37 °C with 
5% CO2. Next, cells were incubated in serum-free complete medium for four hr prior to experiments and pretreated 
with 100 µM of GYY4137 or inhibitor mix (PG and AOAA, 1 mM of each), as indicated. Basal receptor tyrosine 
kinase activity in cells was recorded for 20 min and upon the addition of 150 ng/ml EGF, cells were further recorded 
in 2 hr with the integration time of 1 minute using xCELLigence RTCA DP system (ACEA Biosciences, Can Diego, 
USA). 
 
Detection of Persulfidation of EGFR Pathways (EGF pathway phosphorylation antibody array) 
The persulfidation of the proteins associated to the EGFR pathways were assessed using an EGF pathway phospho 
antibody array comprising of 214 antibodies related to the EGF pathway (Full Moon Biosystems, CA) performed in 
duplcates. The glass strips (barcode: 4000026018, 4000026019, 4000026022 and 4000026023) were equilibrated to 
r.t. 1 hr and dried for 45 mins. They were then blocked with 5% BSA in TBS Tween by rocking at 55 rpm at r.t. for 
45 mins. The slides were then washed extensively with TBS Tween (twice), TBS (twice) and then with H2O (five 
times). Lysates of HeLa cells untreated and treated with 100 ng of EGF for 30 mins and labeled for persulfides, as 
previously explained, were prepared and dissolved in 50 mM Hepes in 2% SDS and further diluted 60 times with 1% 
BSA in TBS up to 6 ml. The glass strips were then submerged in the samples and incubated by rocking at 55 rpm for 
2 hr. The slides were then washed as done previously, left to dry and recorded at 473 nm and 635 nm, using a Typhoon 
FLA 9500 (GE Healthcare). Persulfide levels of each dot for each type of antibody (in pentaplicates on glass strip) 
were averaged and the intensity of their cy5 (635 nm) signal adjusted to the 473 nm signal of the internal standards, 
GAPDH and beta-actin. 
 
Immunoblotting 
Untreated or specifically treated cells were washed twice with cold PBS and harvested in RIPA lysis buffer (50 mM 
Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% IGEPAL and 2% SDS, adjusted to pH 7.4) supplemented with 1% protease 
inhibitor. Cells were scrapped, lysates were collected, homogenized with syringe and needle, and centrifuged at 30,000 
x g for 5 min at 4 °C. Clear lysate was transferred to a new tube. Protein concentration of lysate was determined using 
the DC assay (BioRad). 
Protein samples were resolved by SDS-PAGE and transferred to a nitrocellulose blotting membrane (GE 
Healthcare). Primary antibodies used: CBS (1:1000, sc-133154, Santa Cruz Biotechnology), MPST (1:4000, 
HPA001240, Sigma Aldrich), CTH (MEF cells, 1:4000), CTH (HeLa cells, 1:1000, sc-374249,  Santa Cruz 
Biotechnology), p-ERK (1:1000, sc-7383, Santa Cruz Biotechnology), total-ERK (1:1000, sc-271269, Santa Cruz 
Biotechnology), DJ-1 (1:250, sc-55572, Santa Cruz Biotechnology), DJ-1 Oxidized At C106 (1:1000, HCA024, 
BioRad) and β-tubulin (1:5000, T0198, Sigma Aldrich). Species-specific horseradish-conjugated secondary antibodies 
(1:5000, Santa Cruz Biotechnology) were used for antigen detection and visualized using Clarity™ Western ECL 
Substrate (BioRad). 
 
Immunoprecipitation and detection of DJ-1 Persulfidation, Sulfinylation and Sulfenylation Following H2O2 
Treatment 
MEF cells (CSE+/+ and CSE-/-) were treated with 100 μM H2O2 for 15 or 30 min. For the detection of persulfides NBF-
Cl was used and switched with DCP-Bio1, for sulfenic acid labeling DCP-Bio1 was used and for sulfinic acid labeling 
NEM was used and then labeled with BioDiaAlk, as previously described. Proteins were then precipitated and 
resuspended in 50 mM Hepes with  0.01% SDS at 1 mg/ml. Samples were incubated overnight at 4 °C with anti-DJ-
1 agarose coupled antibody (Santa Cruz Biotechnology, sc-55572 AC). After incubation agarose resins were collected 
by centrifugation (2,000 x g) and washed with 10 mM TBS supplemented with 0.001% Tween (three times) and with 
10 mM TBS  (twice). DJ-1 protein was eluted from the resins for 10 min at 95 °C in 10 mM  TBS  with  3.5% SDS. 
This was then mixed with 4X Laemmli (1:4) supplemented with 10% β-mercaptoethanol  and incubated overnight at 
55 °C. Elution fractions were collected by centrifugation (30,000 xg) and resolved by SDS-PAGE. Protein transfer 
was performed, followed by blocking in 1% BSA in TBS Tween. Monoclonal anti-Biotin-Peroxidase-conjugated 
antibody (1:1000, Sigma) was used for detection and visualized using Clarity™ Western ECL Substrate (BioRad). 
 
Trx-catalyzed reduction of S-sulfocysteine (SSC) 
Cloning and Mutagenesis of Human TRP14 and Trx1 
Genetic sequence of human TRP14 was obtained by generating cDNA from mRNA isolated from human fibroblasts. 
The target sequence was amplified by PCR using forward primer 5’-
ACCATCACGGATCCATGGCCCGCTATGAGGAGG-3’ containing a BamHI restriction site (underlined) and a 
start codon (boldface type), in combination with reverse primer 5’-
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CCGGGGTACCGTTAATCTTCAGAGAACAACATTTCCACCAG-3’ 3’containing a KpnI restriction site 
(underlined) and a stop codon (boldface type). The sequence of the target band was verified by commercial sequencing 
(GATC Biotech). The PCR product was ligated into a pQE80-L expression vector (Qiagen). Human Thioredoxin 1 
(Trx1) was expressed in E. coli using pET28a expression vector. Mutagenesis of the C32S & C35S variants were 
conducted using PCR-mediated site-directed mutagenesis, and the Trx1-pET28a expression plasmid was used as a 
scaffold. 
 
Expression and Purification of Human TRP14 and Trx1 
E. coli BL21 (DE3) Rosetta cells were transformed with the respective expression plasmid and cultured at 37 °C, 140 
rpm in LB medium supplemented with the necessary antibiotics and grown until OD600 reached 0.5. Protein expression 
was induced using isopropyl-β-ᴅ-thiogalactopyranosid (IPTG) at a final concentration of 250 µM. The expression 
temperature and rotation was changed to 30 °C, 120 rpm for TRP14 and 18 °C, 120 rpm for Trx1 variants; expression 
was conducted for ~16 hr. Cells were harvested and lysed in lysis buffer (50 mM potassium phosphate, pH 7.4, 250 
mM NaCl, 10 mM imidazole) supplemented with complete EDTA-free protease inhibitor (Roche). Cells were lysed 
using egg white lysozyme (VWR) and homogenized in an Emulsiflex. Residual nucleic acids were disrupted using a 
sonication rod at 25% amplitude, 10 seconds. The cell lysate was centrifuged at 48000 x g for 45 min, and His-tagged 
proteins were isolated using His-Pur Ni-NTA Superflow Agarose (ThermoFischer) in accordance with the 
manufacturer’s protocol. Elution was performed using lysis buffer supplemented with 250 mM imidazole. Elution 
fractions were analyzed using SDS-PAGE and subsequent Coomassie Brilliant Blue staining, and fractions containing 
increased amounts of target protein were further purified using anion exchange chromatography (Source 15Q, GE 
Healthcare; low salt buffer: 50 mM sodium phosphate, pH 7.4; high salt buffer: 50 mM sodium phosphate, pH 7.4, 1 
M NaCl). Elution was performed in a gradient over five column volumes. Elution fractions were again analyzed using 
SDS-PAGE and Coomassie Brilliant Blue staining. Relevant fractions were buffer exchanged into storage buffer (50 
mM sodium phosphate, pH 7.4, 150 mM NaCl, 100 µM DTT), flash-frozen in liquid nitrogen and stored at -80 °C. 
Proteins were again buffer exchanged after thawing into the relevant experimental buffer. 
 
Coupled Assay of Trx1 / TRP14 and TrxR with Cystine / SSC 
Activities of hTrx and TRP14 with cystine and SSC were recorded measuring NADPH oxidation on a Tecan Infinite 
M200 plate reader, set to record absorption at 340 nm. 3 µM hTrx1 or TRP14, 30 nM TrxR from rat liver (Sigma 
Aldrich) and 250 µM NADPH were used in all measurements. Concentration of cystine or SSC were set at 1 mM. 
Absorption at 340 nm were recorded in 10 seconds intervals over 900 seconds. The initial rate of A340 decrease was 
fitted linearly, and consumption of NAPDH over time was determined using an NADPH extinction coefficient ε340 of 
6020 M-1 cm-1. 
 
Kinetics of Direct Reaction of Human Trx with SSC 
Kinetics of the reaction of hTrx with cysteine persulfide was monitored on FP-8200 spectrofluorometer (Carry Eclipse, 
Agilent) using an excitation wavelength of 280 nm and a maximal emission of 345 nm. Concentration of the enzyme 
was kept at 4 µM while substrate concentrations ranged between 25 µM and 100 µM. Given pseudo first-order 
conditions, observed rate constants kobs were obtained by fitting the decrease in emission at 345 nm at a given SSC 
concentration using a first order exponential decay fit in Origin® analysis software.  
 
Ultra High Resolution ESI-TOF Mass Spectrometry of Reaction Between Trx and SSC 
Human recombinant Trx, Trx C35S and Trx C32S (10 μM) were incubated with 10 μM SSC in 20 mM ammonium 
carbonate buffer pH 7.8 for 5 min and recorded on maXis 5G (Bruker Daltonics) ESI-TOF MS capable of resolution 
of at least 40,000 FWHM, following previously described protocol (Wedmann et al., 2016). 
 
MEF cells Stress Assays  
MEF cells (CSE+/+ and CSE-/-) were plated in 96-well plates at 5 x 104 cells/well. Cells were treated with H2O2 
(concentration range 0.2-2 mM) for 24 hr and the cell survival was assessed by an MTT assay as previously described 
(Liu et al., 2015). 
 
C. elegans Stress Assays 
Worms were initially synchronised by picking approximately 100 young adult worms per strain onto NGM-plates, 
and allowed to lay eggs over 4 hr at 20 °C. The young adults were then removed, and the remaining embryos were 
washed off and collected from the NGM-plates using M9 buffer and transferred to a 15 ml polypropylene tube. The 
worm suspension was centrifuged (850 x g, 1 min) and washed with M9 buffer 3 times. The resulting pellet of embryos 
was re-suspended in 12 ml of M9 buffer, and incubated with agitation (100 rpm) for 24 hr at 20 °C. The synchronised 
L1 worms were collected, centrifuged (850 x g, 1 min) and re-suspended in S-basal buffer. The number and 
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synchronicity of L1 worms was determined and the worms were transferred to an Erlenmeyer, diluted in the respective 
amount of HB101 in S-Basal buffer for a conc. of 60 worms/10 mg of HB101/ml of S-basal buffer. They were then 
incubated with agitation (115 rpm) for 48 hr at 20 °C. The worms were then collected, centrifuged (400 rpm, 1 min), 
washed with M9 buffer 3 times and re-suspended in M9 buffer. 
For experiments with the pretreatment of worms, synchronised young adults (as described above) were 
transferred in an Erlenmeyer with 12 ml of M9 buffer and 500 µM GYY4137 or 100 nM AP39 was added. Worms 
were then incubated for 3 hr at 20 °C with agitation (115 rpm). Worms were centrifuged (400 rpm, 1 min) and re-
suspended in M9 buffer. To assess the effect of CTH on stress resistance, 60 mM paraquat dichloride hydrate or 5 
mM sodium (meta) arsenite dissolved in M9 buffer was added to the synchronised young adult worm suspension and 
plated on a 96 well plate with approximately 5 - 10 worms per well. Viability was monitored by counting dead worms 
over 5 - 6 hr, whilst incubating the plate at 20 °C, with agitation (110 rpm). 
 
Yeast stress Assays and H2S production 
Spot assays were carried out by spotting 5 μl of early exponential phase cultures (OD600=0.5) sequentially diluted 
(approximately 3.5×104 to 3.5 cells) on plates with YPD media supplemented with different concentrations of H2O2 
(0, 1 mM, 2 mM and 5 mM). Growth was recorded after incubation of 24 and 48 hr, at 30 °C. Survival assays were 
done by preparing overnight cultures in YPD media (cell in stationary phase), from which the experimental cultures 
were set, by diluting to OD600=2 in a 5 ml final volume, with or without respective concentrations of H2O2 (0, 10 mM 
and 20 mM). The cultures were subsequently grown in culture tubes for 27 hr at 30 °C with agitation (180 rpm). Yeast 
cells were then washed once in PBS and collected by centrifugation (5000 x g, 3 min). Cells were then resuspended 
in PBS supplemented with 2 µM propidium iodide, at 1×106 cells/ml and incubated for 5 min in the dark. Analysis 
was performed by flow cytometry using 150,000 cells per condition, on a BD Accuri™ C6 and results were analysed 
using the CFlow Plus Software. For the quantification of H2S levels, overnight cultures were washed with PBS and 
diluted as described above. Cell suspensions were incubated with 20 μM MeRho-Az sensor for 45 mins, at 30 °C and 
analysed by flow cytometry. 
 
C. elegans Lifespans 
For the lifespan experiments a synchronous population of worms was obtained by transferring 5-6 young adults on 
medium plates and allowing them to lay eggs over 3 hr at 20 °C. Lifespan measurements were conducted at 20 °C, 
worms were transferred daily during the reproductive period. Death was scored by failure of the animal to move in 
response to gentle prodding with a platinum wire. For lifespan analysis with 1 mM sodium thiosulfate treatment or 5 
mM 2-deoxy-D-glucose (DOG), new plates containing treatments in NGM agar were prepared every second day. 
Lifespan measurements were repeated at least twice unless otherwise stated.  
 
Immunohistochemistry on Rat Brains 
Brains were fixed in 4% paraformaldehyde for 24 hr, dehydrated in a series of increasing concentrations of ethanol 
(30%–100%), enlightened in xylene and embedded in Histowax® (Histolab Product AB, Göteborg, Sweden). Sagittal 
plane of each brain was sectioned at 5 µm thickness on a rotary microtome (RM 2125RT Leica Microsystems, Wetzlar, 
Germany). Sections were placed on Superfrost Ultra Plus® manufactured slides and used for immunohistochemical 
staining. In brief, after tissue deparaffinization, brain sections were exposed to heat-induced antigen retrieval to 
demask target antigens. Slides were placed in a container and covered with 0.01 mol/l sodium citrate buffer pH 6.0, 
and then heated at 750 W in microwave oven for 3 x 7 min. Next, sections were incubated with 0.3% H2O2 in MeOH 
for 15 min to block endogenous peroxidase. Slides were washed in PBS (pH 7.4) and reduction of non-specific 
background staining was achieved by incubation with normal swine (1:10, Dakopatts) and donkey serum (1:10, 
Abcam) for 45 min at room temperature. Afterward, sections were incubated with rabbit-anti-human: CBS (1:200, sc-
67154, Santa Cruz Biotechnology), MPST (1:500, HPA001240, Sigma Aldrich), and with mouse-anti-human 
CTH/CSE antibody (1:200, sc-365382, Santa Cruz Biotechnology), overnight at 4 °C. For the negative control, the 
primary antibody was substituted with PBS. After washing 5 min in PBS, brain tissue sections were incubated with 
swine-anti-rabbit and donkey-anti-mouse IgG-horseradish peroxidase (HRP; 1:100; Dakopatts and Abcam) for 1 hr at 
room temperature. Slides were washed in PBS and visualization was performed using Dako liquid 
diaminobenzidinetetrahydrochloride (DAB) substrate chromogen system (Dako North America Inc.) at concentrations 
suggested by the manufacturer. Hematoxylin was used as counterstain and slides were mounted in DPX medium 
(Sigma-Aldrich). 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
The experiments were performed at least in triplicates. Key methodological experiments were verified by at least three 
different researchers in three different labs. Protein expression levels, persulfidation, sulfenylation and sulfinylation 
levels were compared with an unpaired t test with *p < 0.05 and **p < 0.01. Lifespan data were analyzed using 
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Kaplan-Meier survival analysis to detect statistical differences. Plotting of the data were performed using GraphPad 




Figure S1. Testing dimedone switch method on low molecular weight and protein persulfides. Related to Figure 
1.  
(A) Original tag switch strategy for persulfide labeling.  
(B) ESI-TOF-MS spectrum of the reaction mixture containing 100 μM nmc-penicillamine persulfide, 100 μM NBF-
Cl, and 500 μM dimedone (ammonium carbonate buffer, pH 7.4, 23 °C). 100 μM nmc-penicillamine persulfide and 
100 μM NBF-Cl were mixed for 10 min and after the completion of the reaction dimedone was added and the reaction 
was monitored by ESI-TOF-MS. (C-E) Speciation of the observed (red) peaks and simulation of the isotopic 
distribution for each species (black).  
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(F) MS/MS spectrum of m/z 344 peak. Asterisk marks the position of m/z 344 peak that decomposed to fragments 
which correspond to species shown in Figure 1C.  
(G) UV-vis spectral changes upon addition of 100 μM NBF-Cl to 23 μM HSA-SH (50 mM phosphate buffer, pH 7.4 
with 1% SDS, at 37 °C). 
(H) UV-vis spectral changes caused by subsequent addition of 100 μM dimedone to a reaction mixture from (G). 
Inset: Kinetic trace at 420 nm. 
(I) UV-vis spectral changes upon addition of 100 μM NBF-Cl to 23 μM HSA-SOH (50 mM phosphate buffer, pH 7.4 
with 1% SDS, at 37 °C).  
(J) UV-vis spectral changes caused by subsequent addition of 100 μM dimedone to a reaction mixture from (I). Inset: 
Kinetic trace at 420 nm.  
(K) UV-vis spectral changes upon addition of 100 μM NBF-Cl to 23 μM HSA-SOH (50 mM phosphate buffer, pH 
7.4 with 1% SDS, at 37 °C). 
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Figure S2. Probing the selectivity and conditions for persulfide labeling by dimedone switch method. Related 
to Figure 2. 
(A) Human serum albumin (HSA), sulfenylated HSA and HSA persulfide were treated with 5 mM NBF-Cl (50 mM 
phosphate buffer, pH 7.4 with 1% SDS, at 37 °C), proteins precipitated and cleaned from NBF-Cl and then incubated 
with 100 M DCP-Bio1 for 30 min at 37 °C. Following the precipitation and washing from the excess of DCP-Bio1, 
proteins were resuspended in 50 mM phosphate buffer, pH 7.4 and spotted on nitrocellulose membrane. Detection of 
dimedone-labeled adduct was done with streptavidin-Cy5. In addition, the same samples were incubated with 
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streptavidin magnetic beads and after careful washing, the bound protein was eluted by boiling with Laemmli buffer 
5 min at 95 °C. Eluted proteins were separated by electrophoresis and in-gel fluorescence of NBF-protein adduct 
detected by Typhoon 9500.  
(B) Detection of GAPDH-persulfide switch labeled with DCP-Bio1. Proteins were spotted on nitrocellulose membrane 
and biotinylation detected with streptavidin-Cy5. Green fluorescence (NBF-protein adduct) serves as a measure of 
protein load.  
(C) MS/MS of peptide fragment obtained by trypsin digestion of bovine rhodanese (TST) shows labeling of C248 
with hydrolyzed DCP-Bio1. Full MS data are given in Data S1-2. 
(D) Commercially available TST was either incubated with thiosulfate or DTT to form fully persulfidated or reduced 
form, respectively. 20 M enzyme was mixed with 50 M NBF-Cl and persulfide visualized by using Daz-2/Cy5 
CuAAC. While both untreated and thiosulfate treated showed Cy5 signal, the green fluorescence signal was 
significantly reduced in fully persulfidated enzyme, despite the same load. On the other hand, green fluorescence 
signal was much stronger in fully reduced enzyme, suggesting that at low NBF-Cl/protein ratio, switch caused by 
dimedone-based probe could affect the intensity of green fluorescence.  
(E) When 1 mM NBF-Cl was used to initially react with 20 M of TST, in an experiment similar to that shown in 
(D), the Cy5 signal was reduced when DTT treated TST was used, whilst the green fluorescence signal remained 
stable, suggesting that it can be used as a measure of the total protein load. It is worth mentioning that it is known that 
DTT is unable to fully reduce TST. (Tandon and Horowitz, 1989) 
(F) The reaction of human serum albumin with click reagents in all possible combinations (left) show no nonselective 
labeling. The same samples run 2 weeks after being kept at -20 °C. Small unselective labeling can be observed in 
sample treated with Cy5-alkyne, Cu(II)-TBTA and ascorbate (probably due to the direct coupling of alkynes for 
thiols), but the signal was still negligible when compared to the signal obtained for labelled HSA-SSH. 
(G) In-gel detection of protein persulfidation levels in HeLa cells, labeled with Daz-2/Cy5-alkyne CuAAC, after using 




Figure S3. Broad applicability of dimedone switch method. Related to Figure 3. 
(A-B) Protein persulfidation levels and corresponding CSE and CBS expression levels in wild type and CSE-/- cells 
of passage (P) 2 and 10. 
(C) In situ labeling of intracellular protein persulfidation detected by confocal microscopy. Related to the Figure 3K. 
(D-F) High-resolution images of protein persulfidation in CSE+/+, CSE-/- and CSE+/+ MEF cells treated with 2 mM D-
cysteine for 1 hr, obtained by wide-field fluorescence deconvolution. 
(G) Protein evolution phylogenic tree showing the common origin of cysteine containing MnSOD.  
(H) MS/MS spectra of peptide obtained by trypsin digestion of MnSOD containing C193 labeled with hydrolyzed 
DCP-Bio1.  







Figure S4. Protein persulfidation is an integral part of cellular response to H2O2 and RTK activation. Related 
to Figures 4 and 5.  
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(A) Representative blot showing the effect of GYY4137 (200 μM) on H2O2 (500 μM)-induced sulfenylation in CSE+/+ 
and CSE-/- MEF cells. Sulfenylation was visualized by streptavidin-488 and normalized against GAPDH. n=3 
(B) Evaluation of DJ-1 immunoprecipitation experiments shown in Figure 4E. Values represent mean ± SD. n=4. 
(C) Expression levels of H2S producing enzymes, MST, CBS and CSE in HeLa cells after treatment with EGF for the 
indicated amount of time. Densitometric analysis of data from 3 independent experiments was normalized against β-
tubulin. Values represent mean ± SD.  
(D) Representative images showing protein persulfidation and sulfenylation, used for Figure 5C. HeLa cells were 
pretreated with 200 μM GYY4137 and then exposed to 100 ng/ml EGF for the indicated amount of time. Persulfidation 
was detected in-gel by measuring Cy5/488 signal ration. Sulfenylation was visualized by streptavidin-488 and 
normalized against β-tubulin.  
(E) Representative images showing protein persulfidation and sulfenylation, used for Figure 5D. HeLa cells were 
pretreated with 2 mM mixture of AOAA and PG (1:1, 30 min) and then exposed to 100 ng/ml EGF for the indicated 
amount of time. Persulfidation was detected in-gel by measuring Cy5/488 signal ration. Sulfenylation was visualized 
by streptavidin-488 and normalized against β-tubulin. 
(F) Representative images showing protein persulfidation and sulfenylation, used for Figure 5E. HUVEC were treated 
with 40 ng/ml VEGF for the indicated amount of time. Persulfidation was detected in-gel by measuring Cy5/488 signal 
ratio. Sulfenylation was visualized by streptavidin-488 and normalized against β-tubulin.   
(G) Representative images showing protein persulfidation used for Figure 5F. SH-SY5Y cells were treated with either 
100 nM or 200 nM insulin.  
(H) Sulfenylation changes in SH-SY5Y cells treated with either 100 nM or 200 nM insulin. n = 3. 
(I-J) Changes in persulfidation and sulfenylation dynamics in CSE+/+ and CSE-/- MEF cells after treatment with 100 
ng/ml of EGF. Representative images (I) and quantification of the change (J). Values are given as mean ± SD from n 
= 3. 
(K) Inhibition of H2S production by the pretreatment of HeLa cells with 2 mM mixture of AOAA and PG (1:1) for 30 
min and subsequent treatment with EGF causes changes in phosphorylation levels of pERK. Expression levels of 
pERK were normalized against total ERK expression in the same immunoblot, while total ERK was normalized 
against β-tubulin. Densitometric analysis of the data from three independent experiments is shown as mean ± SD.  
(L) Antibody microarray-like approach was used to address persulfidation status of EGFR, PTEN, PTP1B and 
SHPTP2 from HeLa cells treated with 100 ng/mL EGF for the indicated amount of time. Original readouts obtained 
by Typhoon FLA 9500 are pseudo-coloured in ImageJ to visually enhance the changes in the signal. Quantification 
of the data from two independent experiments.  
(M-R) Persulfidation levels of ß-catenin (M), actin (N), E-cadherin (O), Dok-2 (P), VAV1 (Q), RhoA (R) in HeLa 
cells treated or not with 100 ng/ml EGF for 30 min, measured using EGFR pathway microarray glass slips. Related to 






Figure S5. Trx-catalyzed reduction of S-sulfocysteine (SSC) and protection against ROS-induced death. 
Related to Figure 6 
(A) Deconvoluted mass spectra of 10 M C32S Trx before (black) and after the reaction with 10 M SSC showing 
no difference.  
(B) ESI-TOF-mass spectra of 10 M C35S Trx before (black) and after the reaction with 10 M SSC (red). The arrow 
indicates the peak that is absent in the control spectrum.  
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(C) Kinetics of human Trx (4 μM) oxidation with 25 μM (blue line) and 50 μM SSC (red line), followed by tryptophan 
fluorescence (λex 280 nm) changes. Spontaneous oxidation of Trx alone is shown in black.  
(D-E) Activities of human Trx (D) with cystine and SSC and TRP14 with SSC (E)  were recorded measuring NADPH 
oxidation on a Tecan Infinite M200 plate reader, set to record absorption at 340 nm. 3 µM human Trx1 or TRP14, 30 
nM TrxR from rat liver and 250 µM NADPH were used in all measurements. Concentration of cystine or SSC were 
set at 1 mM. Absorption at 340 nm was recorded. The initial rate of A340 decrease was fitted linearly, and consumption 
of NAPDH over time was determined using an NADPH extinction coefficient ε340 of 6020 M-1 cm-1. 
(F) Metabolic pathways for H2S biosynthesis in S. cerevisae. 
(G) Growth curves for wild type, Δcys3, Δcys4 and Δtum1 mutants of S.cerevisiae. 
(H) Persulfidation level in wild type, Δcys3, Δcys4 and Δtum1 mutants of S. cerevisiae. 
(I) Drop dilution assay for evaluating the sensitivity of Δcys3, Δcys4 and Δtum1 mutants to 2 mM H2O2. 
(J) Flow cytometric analysis of H2S levels (green fluorescence, FL1A) in different mutants of S. cerevisiae.  
(K) The effect of short-term (3 hr) preexposure to GYY4137 (500 M) or AP39 (100 nM) on survival rate of C. 
elegans treated with 60 mM paraquat for 5 hr.  
(L) The effect of short-term (3 hr) pre-exposure to GYY4137 (500 M) on survival rate of N2 and cth-1 C. elegans 











Figure S6. P-SSH levels correlate with aging. Related to Figure 7. 
(A) Lifespan analysis of N2, cth-1 and mpst-3 mutant strains. n > 110 per each line.  
(B) Persulfidation levels in N2 C. elegans at different days of adulthood. Intensity of persulfidation is expressed as 
Cy5/488 ratio Values represent mean ± SD from three different experiments.   
(C) Expression levels of CSE, CBS and MPST in brain extracts from 1, 6, 12 and 24 months old rats. GAPDH is used 
as a loading control. Representative blots form n=3. 
(D) Persulfidation levels, CSE, CBS and MPST expression levels in liver extracts from 1, 6, 12 and 24 months old 
rats. GAPDH is used as a loading control. Representative images from n=3. 
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(E) Expression levels of CSE, CBS and MPST in muscle extracts from 2 and 12 months old mice. GAPDH is used as 
a loading control. n=3. 

























Table S1. List of proteins found to be endogenously persulfidated in human red blood cells.* 




UniProtKB -10logP Peptides 
Coverage 
% 
MW (Da) Ref. 
1 Carbonic anhydrase 1 P00915 308.61 54 73 28,870 
(Delobel et al., 
2016) 
2 
Spectrin alpha chain, 
erythrocytic 1 
P02549 266.65 101 43 280,014 
(Zaccarin et al., 
2014) 
3 
Spectrin beta chain, 
erythrocytic 
P11277 248.03 61 30 246,468 
(Zaccarin et al., 
2014) 
4 Ankyrin 1 P16157 218.79 32 21 206,265 
(Yang et al., 
2012; Zaccarin 
et al., 2014) 
5 Catalase P04040 218.65 35 45 59,756 
(Delobel et al., 
2016; Yang et 
al., 2012) 
6 Flavin reductase P30043 197.55 17 64 22,119 
(Delobel et al., 
2016) 
7 
Band 3 anion transport 
protein 
P02730 197.26 23 26 101,792 
(Zaccarin et al., 
2014) 
8 Carbonic anhydrase 2 P00918 192.22 25 65 29,246 
(Delobel et al., 
2016) 
9 Peroxiredoxin 2 P32119 187.35 26 59 21,892 
(Delobel et al., 
2016; Zaccarin 




P07738 135.16 14 51 30,005 





P04406 131.26 9 39 36,053 
(Valentine et 
al., 1987; 





Q99497 129.49 8 50 19,891 
(Delobel et al., 
2016) 
13 Peroxiredoxin 1 Q06830 123.63 10 45 22,110 
(Delobel et al., 
2016) 










P00491 114.54 7 30 32,118 
(Delobel et al., 
2016) 
17 Methanethiol oxidase  Q13228 112.56 7 17 52,391  
18 Protein 4.1 P11171 112.26 7 10 97,017 
(Yang et al., 
2012; Zaccarin 




P55072 164.3 16 21 89,322 
(Yang et al., 
2012) 
20 Peroxiredoxin 6 P30041 153 11 52 25,035 





P31948 140.13 11 19 62,639 





P60174 125.54 6 31 30,791 
(Delobel et al., 
2016) 





Heat shock cognate 71 
kDa protein 
P11142 119.28 10 20 70,898 
(Delobel et al., 









P07195 111.71 10 25 36,638 
(Delobel et al., 
2016) 
27 Alpha enolase P06733 107.69 7 21 47,169 
(Delobel et al., 
2016; Valentine 
et al., 1987; 
Yang et al., 
2012) 
28 
T-complex protein 1 
subunit theta 
P50990 106.44 7 16 59,621  
29 
Low molecular weight 
phosphotyrosine protein 
phosphatase 
P24666 103.76 5 38 18,042  
30 Alpha adducin P35611 99.94 7 11 80,955 
(Yang et al., 
2012) 
31 
Erythrocyte band 7 
integral membrane protein 
P27105 98.78 7 29 31,731 




initiation factor 5 alpha 
P55010 95.91 4 31 49,223  
33 
Heat shock protein HSP 
90-alpha 
P07900 94.83 7 13 84,660  









activating enzyme 1 
Q5JRR6 89.97 4 5 56,852 




terminal hydrolase 14 
P54578 87.61 4 13 56,069 
(Yang et al., 
2012) 
38 β adducin P35612 87.23 3 5 80,854  
39 Hsc70 interacting protein P50502 85.19 4 12 41,332  
40 
Proteasome subunit alpha 
type-5 
P28066 82.21 3 18 26,411  
41 Thioredoxin P10599 79.82 4 31 11,737  
42 
Rab GDP dissociation 
inhibitor β 
P50395 79.5 4 10 50,663 





P08263 78.34 3 13 25,631 




protein band 4.2 
P16452 75.97 4 8 77,009 
(Zaccarin et al., 
2014) 
45 
Rho GDP dissociation 
inhibitor 1 
P52565 75.91 3 16 23,207  
46 Dematin Q08495 75.59 4 12 45,514  
47 Ankyrin 3 Q12955 75.45 5 1 480,410 





P25325 68.09 4 9 33,178  
49 Carbonic anhydrase 3 P07451 69.76 3 14 29,557 









O95747 68.46 4 8 58,022  
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52 
Copper chaperone for 
superoxide dismutase 
O14618 67.22 3 10 29,041  
53 Transaldolase P37837 66.97 4 9 37,540 
(Delobel et al., 
2016) 
54 Protein S100-A6 P06703 80.68 5 43 10,180  
55 Malate dehydrogenase P40925 60.29 3 13 36,426 




ligase catalytic subunit 
P48506 59.76 2 10 72,766  
57 
Proteasome subunit alpha 
type-1 
P25786 59.18 2 10 29,556  
58 14-3-3 protein beta/alpha P31946 50.89 2 8 28,082  
* The table consists of proteins identified by at least 2 reliable peptides and -10logP>50, obtained by trypsin and/or 
chymotrypsin digestion.  
 
 
 
